Patient interface with underlay and membrane

The patient interface, with its flexible frame and adjustable sealing structure, solves the problem of mismatch between the mask and face in existing respiratory distress treatment devices, improving sealing and comfort, and enhancing treatment compliance.

CN119013065APending Publication Date: 2024-11-22RESMED PTY LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380027492.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-30
Filing Date
2023-03-30
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing respiratory disorder treatment devices and masks have issues with comfort, cost, ease of use, and manufacturability. In particular, the mismatch between the mask and the patient's face leads to poor sealing, which affects treatment adherence.

Method used

A patient interface was designed with a flexible frame and an adjustable seal-forming structure, including a foam underliner and a fabric membrane portion, to accommodate different face widths and provide a comfortable and cost-effective seal.

Benefits of technology

It improves patient compliance with respiratory therapy, enhances sealing and comfort, adapts to different facial shapes, and reduces manufacturing and usage costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119013065A_ABST
    Figure CN119013065A_ABST
Patent Text Reader

Abstract

A patient interface includes: a frame partially forming an inflation chamber and including a channel around a perimeter of the frame; at least one pair of headband connectors connected to the frame; a seal-forming structure connected to the frame and partially forming an inflation chamber wherein the seal-forming structure comprises a lower cushion and a membrane portion connected to the lower cushion and configured for inflating, in use, to form a seal against the nose bump region and the ala nasi of the patient's nose, the seal-forming structure is further configured to form a seal around the mouth of the patient; and wherein the lower liner of the seal-forming structure comprises a connection portion on a non-patient-facing side of the lower liner, the connection portion configured to be received in the channel of the frame to releasably connect the seal-forming structure to the frame.
Need to check novelty before this filing date? Find Prior Art

Description

Background Art 1.1 Technical Field

[0002] The present technology relates to one or more of the screening, diagnosis, monitoring, treatment, prevention and improvement of breathing-related disorders. The present technology also relates to medical devices or equipment and their uses.

[0003] 1.2 Description of related technologies

[0004] 1.2.1 Human respiratory system and its disorders

[0005] The human respiratory system facilitates gas exchange. The nose and mouth form the entrance to the patient's airway.

[0006] The airways consist of a series of branching tubes that become narrower, shorter, and more numerous as they penetrate deeper into the lungs. The primary function of the lungs is gas exchange, allowing oxygen to pass from the inhaled air into the venous blood and expel carbon dioxide in the opposite direction. The trachea is divided into the left main bronchi and the right main bronchi, which eventually divide into terminal bronchioles. The bronchi constitute the conducting airways and do not participate in gas exchange. Further branches of the airways lead to the respiratory bronchioles and ultimately to the alveoli. The alveolar region of the lungs is the area where gas exchange occurs and is called the respiratory zone. See Respiratory Physiology, 9th edition, published by John B. West, Lippincott Williams & Wilkins, 2012.

[0007] There is a range of breathing disorders. Some disorders can be characterised by specific events such as apnea, hypopnea and hyperpnea.

[0008] Examples of breathing disorders include obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory insufficiency, obesity hyperventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular disease (NMD), and chest wall disorders.

[0009] Obstructive sleep apnea (OSA), a form of sleep disordered breathing (SDB), is characterized by episodes of obstruction or blockage of the upper airway during sleep. This is caused by an abnormally small upper airway in the area of ​​the tongue, soft palate, and posterior oropharyngeal wall, coupled with a normal loss of muscle tone during sleep. The condition causes affected patients to stop breathing, typically for periods of 30 to 120 seconds, sometimes 200 to 300 times per night. It often leads to excessive daytime sleepiness and can lead to cardiovascular disease and brain damage. Comorbid symptoms are a common disorder, especially in middle-aged overweight men, but those affected may not be aware of the problem. See U.S. Patent No. 4,944,310 (Sullivan).

[0010] Cheyne-Stokes respiration (CSR) is another form of sleep-disordered breathing. CSR is a disorder of the patient's respiratory controller in which there are rhythmic alternating cycles of waxing and waning ventilation called CSR cycles. CSR is characterized by repeated hypoxia and reoxygenation of arterial blood. CSR can be harmful because of the repeated hypoxia. In some patients, CSR is associated with repeated arousals from sleep, which results in severe sleep disruption, increased sympathetic activity, and increased afterload. See U.S. Patent No. 6,532,959 (Berthon-Jones).

[0011] Respiratory failure is a term for a respiratory disorder in which the lungs cannot take in enough oxygen or exhale enough CO. 2 to meet the needs of the patient. Respiratory failure can include some or all of the following disorders.

[0012] People with respiratory insufficiency (a form of respiratory failure) may experience abnormal shortness of breath when exercising.

[0013] Obesity hyperventilation syndrome (OHS) is defined as the combination of severe obesity and chronic hypercapnia during wakefulness in the absence of other known causes of hypoventilation. Symptoms include dyspnea, morning headache, and excessive daytime sleepiness.

[0014] Chronic obstructive pulmonary disease (COPD) encompasses any of a group of lower airway diseases that share certain common features. These include increased resistance to air flow, a prolonged expiratory phase of breathing, and loss of the lungs' normal elasticity. Examples of COPD are emphysema and chronic bronchitis. COPD is caused by chronic smoking (a major risk factor), occupational exposure, air pollution, and genetic factors. Symptoms include: dyspnea on exertion, chronic cough, and sputum production.

[0015] Neuromuscular disease (NMD) is a broad term that encompasses a number of diseases and conditions that impair muscle function either directly through intrinsic muscle pathology or indirectly through neuropathology. Some NMD patients are characterized by progressive muscle damage that leads to loss of ambulation, wheelchair confinement, dysphagia, respiratory muscle weakness, and ultimately death from respiratory failure. Neuromuscular diseases can be divided into rapidly progressive and slowly progressive: (i) rapidly progressive conditions characterized by muscle damage that worsens over months and leads to death within years (e.g., amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD) in adolescents); (ii) variable or slowly progressive conditions characterized by muscle damage that worsens over time and only slightly reduces life expectancy (e.g., limb-girdle, facioscapulohumeral muscular dystrophy, and myotonic dystrophy). Symptoms of respiratory failure in NMD include: increasing general weakness, dysphagia, dyspnea during exercise and at rest, fatigue, lethargy, morning headaches, and difficulty concentrating and mood changes.

[0016] The chest wall is a group of thoracic deformities that result in inefficient connections between the respiratory muscles and the thorax. These disorders are often characterized by restrictive defects and have the potential for long-term hypercapnic respiratory failure. Scoliosis and / or kyphoscoliosis can cause severe respiratory failure. Symptoms of respiratory failure include: dyspnea during exertion, peripheral edema, orthopnea, recurrent chest infections, morning headaches, fatigue, poor sleep quality, and loss of appetite.

[0017] A range of treatments have been used to treat or ameliorate such conditions. In addition, such treatments can be used to prevent breathing disorders in otherwise healthy individuals. However, these treatments have a number of disadvantages.

[0018] 1.2.2 Treatment

[0019] Various respiratory therapies, such as continuous positive airway pressure (CPAP) therapy, non-invasive ventilation (NIV), invasive ventilation (IV), and high flow therapy (HFT) have been used to treat one or more of the above-mentioned respiratory disorders.

[0020] 1.2.2.1 Respiratory pressure therapy

[0021] Respiratory pressure therapy is the supply of air to the airway entrance at a controlled target pressure that is nominally positive relative to atmosphere throughout the patient's breathing cycle (as opposed to negative pressure therapy such as canister or tube ventilators).

[0022] Continuous positive airway pressure (CPAP) therapy has been used to treat obstructive sleep apnea (OSA). The mechanism of action is that the continuous positive airway pressure acts as a pneumatic splint and can prevent upper airway occlusion, such as by pushing the soft palate and tongue forward and away from the posterior oropharyngeal wall. Treatment of OSA treated by CPAP can be voluntary, so if the patient finds the device used to provide such treatment to be any one or more of: uncomfortable, difficult to use, expensive, and unsightly, the patient may choose not to comply with the treatment.

[0023] Non-invasive ventilation (NIV) provides ventilation support to the patient through the upper airway to help the patient breathe and / or maintain appropriate oxygen levels in the body by performing some or all of the work of breathing. Ventilatory support is provided via a non-invasive patient interface. NIV has been used to treat CSR and respiratory failure in the form of OHS, COPD, NMD, and chest wall disorders. In some forms, the comfort and effectiveness of these treatments can be improved.

[0024] Invasive ventilation (IV) provides ventilation support to patients who are no longer able to breathe effectively and can be provided using a tracheostomy tube. In some forms, the comfort and effectiveness of these treatments can be improved.

[0025] 1.2.2.2 Mobile therapy

[0026] Not all respiratory therapies are designed to deliver a prescribed therapeutic pressure. Some respiratory therapies are designed to deliver a prescribed respiratory volume by delivering an inspiratory flow rate curve (possibly superimposed on a positive baseline pressure) over a target duration. In other cases, the interface to the patient's airway is "open" (unsealed), and the respiratory therapy may simply supplement the patient's own spontaneous breathing with a flow of conditioned or enriched gas. In one example, high flow therapy (HFT) is the provision of a continuous, heated, humidified flow of air to the airway entrance through an unsealed or open patient interface at a "therapeutic flow" that remains approximately constant throughout the respiratory cycle. The therapeutic flow rate is nominally set to exceed the patient's peak inspiratory flow rate. HFT has been used to treat OSA, CSR, respiratory failure, COPD, and other respiratory disorders. One mechanism of action is that the high flow of air at the airway entrance provides a constant level of respiratory function by flushing or washing out exhaled CO from the patient's anatomical dead space. 2 To improve ventilation efficiency. Therefore, HFT is sometimes called deadspace therapy (DST procedure). Other benefits may include increased warmth and humidification (which may be beneficial in secretion management) and the possibility of appropriately increasing airway pressure. As an alternative to a constant flow rate, the therapeutic flow rate can follow a curve that varies during the respiratory cycle.

[0027] Another form of flow therapy is long-term oxygen therapy (LTOT) or supplemental oxygen therapy. A physician may prescribe a continuous flow of oxygen-enriched gas delivered to a patient's airway at a specified oxygen concentration (from 21%, the oxygen fraction of ambient air, to 100%) at a specified flow rate (e.g., 1 liter per minute (LPM), 2 LPM, 3 LPM, etc.).

[0028] 1.2.2.3 Supplemental oxygen

[0029] For some patients, oxygen therapy can be combined with respiratory pressure therapy or HFT by adding supplemental oxygen to the pressurized air flow. When oxygen is added to respiratory pressure therapy, this is called RPT with supplemental oxygen. When oxygen is added to HFT, the resulting therapy is called HFT with supplemental oxygen.

[0030] 1.2.3 Respiratory therapy system

[0031] These respiratory therapies can be provided by a respiratory therapy system or device.Such systems and devices can also be used to screen, diagnose, or monitor a condition without treating it.

[0032] A respiratory therapy system may include a respiratory pressure therapy device (RPT device), air circuit, humidifier, patient interface, oxygen source, and data management.

[0033] Another form of therapy system is a mandibular repositioning device.

[0034] 1.2.3.1 Patient interface

[0035] The patient interface can be used to couple the respiratory device to its wearer, for example by providing a flow of air to the entrance of the airway. The flow of air can be provided to the patient's nose and / or mouth via a mask, to the mouth via a tube, or to the patient's trachea via a tracheostomy tube. Depending on the treatment to be applied, the patient interface can form a seal with an area such as the patient's face, thereby causing gas to flow at a pressure that is sufficiently different from ambient pressure (e.g., approximately 10 cmH 2 relative to ambient pressure). 2 For other forms of therapy, such as oxygen delivery, the patient interface may not include a pressure sufficient to deliver approximately 10 cmH 2 O gas is delivered at a positive pressure to seal the airway. For flow therapy such as nasal HFT, the patient interface is configured to blow air into the nostrils, but specifically avoids a complete seal. An example of such a patient interface is a nasal cannula.

[0036] Certain other mask systems may not be functionally suitable for use in this field. For example, a purely decorative mask may not be able to maintain appropriate pressure. Mask systems used for underwater swimming or diving may be configured to prevent the entry of water from a higher pressure outside, but not to maintain the internal air at a pressure higher than the ambient pressure.

[0037] Certain masks may be clinically undesirable for the present technology, for example where they block airflow through the nose and only allow it through the mouth.

[0038] If certain masks require the patient to insert a portion of the mask structure into their mouth to create and maintain a seal with their lips, this may be uncomfortable or impractical with the present technology.

[0039] Certain masks may not be feasible for use while sleeping, such as when sleeping on one's side in bed with the head on a pillow.

[0040] The design of a patient interface presents several challenges. The face has a complex three-dimensional shape. The size and shape of the nose and head vary greatly between individuals. Because the head is composed of bone, cartilage, and soft tissue, different areas of the face respond differently to mechanical forces. The jaw or mandible can move relative to other skeletal supports of the skull. The entire head can move during a period of respiratory therapy.

[0041] Due to these challenges, some masks face one or more of the following problems: obtrusive, unsightly, expensive, disproportionate, difficult to use, and uncomfortable, especially when worn for a long time or when the patient is not familiar with the system. The wrong size mask may lead to reduced compliance, reduced comfort, and poor patient outcomes. Masks designed only for pilots, masks designed to be part of personal protective equipment (e.g., filtering masks), SCUBA masks, or masks designed to apply anesthetics are acceptable for their original purposes, but for long periods of time (e.g., several hours), such masks are not as comfortable as ideal. This discomfort may lead to reduced patient compliance with treatment. This is even more true if the mask is worn during sleep.

[0042] CPAP therapy is very effective in treating certain breathing disorders, assuming the patient complies with the therapy. If the mask is uncomfortable or difficult to use, the patient may not comply with the therapy. Since patients are often advised to clean their masks regularly, if the mask is difficult to clean (e.g., difficult to assemble or disassemble), the patient may not be able to clean their mask, which may affect patient compliance.

[0043] While a mask used for other applications (such as pilots) may not be suitable for treating sleep-disordered breathing, a mask designed to treat sleep-disordered breathing may be suitable for use in other applications.

[0044] For these reasons, patient interfaces for delivering CPAP during sleep have emerged as a distinct field.

[0045] Some prior art patient interfaces comprise a cushion module having a rigid shell having a predetermined shape based on the anthropometry of an imaginary person in the middle of a selected size range. As a result, the sealing and comfort success of a cushion module having a given size may be closely related to the correlation between the anthropometry of the patient and the anthropometry of the imaginary person on which the design is based. This may result in the need to "fit" the patient (perhaps with the help of an appropriately qualified professional) to a particular size cushion module and / or a particular type of interface. This may also result in the need to manufacture a range of different sizes of cushion modules to ensure that a wide range of patients can find a size that fits them.

[0046] 1.2.3.1.1 Sealing structure

[0047] The patient interface may include a seal-forming structure. Since it is in direct contact with the patient's face, the shape and configuration of the seal-forming structure may directly affect the effectiveness and comfort of the patient interface.

[0048] The patient interface can be characterized in part according to the design intent of the seal-forming structure to engage with the face when in use. In one form of patient interface, the seal-forming structure may include a first sub-portion that forms a seal around the left nostril and a second sub-portion that forms a seal around the right nostril. In one form of patient interface, the seal-forming structure may include a single element that surrounds both nostrils when in use. This single element may be designed to, for example, cover the upper lip area and the bridge of the nose area of ​​the face. In one form of patient interface, the seal-forming structure may include an element that surrounds the mouth area when in use, for example, by forming a seal on the lower lip area of ​​the face. In one form of patient interface, the seal-forming structure may include a single element that surrounds both nostrils and the mouth area when in use. These different types of patient interfaces may be given various names by their manufacturers, including nasal masks, full-face masks, nasal pillows, nasal sprays, and oronasal masks.

[0049] A seal-forming structure that may be effective in one area of ​​a patient's face may not be suitable in another area, for example, because the shape, structure, variability, and sensitive areas of the patient's face are different. For example, a seal on swimming goggles that covers a patient's forehead may not be suitable for use on the patient's nose.

[0050] Certain seal-forming structures may be designed for mass manufacturing so that one design is appropriate, comfortable, and effective for a wide range of different face shapes and sizes. To the extent there is a mismatch between the shape of the patient's face and the seal-forming structure of a mass-manufactured patient interface, one or both must adapt to form a seal.

[0051] One type of seal-forming structure extends around the periphery of the patient interface and is intended to seal against the patient's face when a force is applied to the patient interface while the seal-forming portion is in facing engagement with the patient's face. The seal-forming structure may include an air or fluid-filled cushion, or a molded or formed surface of a resilient sealing element made of an elastomer (e.g., rubber). With this type of seal-forming structure, if the fit is inadequate, there will be a gap between the seal-forming structure and the face, and additional force will be required to force the patient interface against the face to achieve a seal.

[0052] Another type of seal-forming structure incorporates a sheet seal of thin material, such as silicone, around the periphery of the mask to provide a self-sealing action against the patient's face when positive pressure is applied within the mask. Similar to the previous types of seal-forming portions, if the fit between the face and the mask is not good, additional force may be required to achieve a seal, or the mask may leak. In addition, if the shape of the seal-forming structure does not match the shape of the patient, it may wrinkle or bend during use, causing leaks.

[0053] Another type of seal-forming structure may include friction-fit elements, such as for insertion into a nostril, however some patients find these uncomfortable.

[0054] Another form of seal-forming structure can use adhesive to achieve the seal. Some patients may find it inconvenient to frequently apply and remove adhesive from their face.

[0055] A series of patient interface seal forming structure technologies are disclosed in the following patent applications assigned to ResMed Limited: WO 1998 / 004,310; WO 2006 / 074,513; WO 2010 / 135,785.

[0056] One form of nasal pillow is found in the Adam Circuit manufactured by Puritan Bennett. Another nasal pillow or nasal spray is the subject of U.S. Patent 4,782,832 (Trimble et al.), assigned to Puritan-Bennett Corporation.

[0057] ResMed Ltd. has manufactured the following products incorporating nasal pillows: SWIFT™ Nasal Pillows Mask, SWIFT™ II Nasal Pillows Mask, SWIFT™ LT Nasal Pillows Mask, SWIFT™ FX Nasal Pillows Mask, and MIRAGE LIBERTY™ Full Face Mask. The following patent applications assigned to Resmed Ltd. describe examples of nasal pillow masks: International Patent Application WO 2004 / 073,778 (which describes the Resmed Ltd. SWIFT TMnasal pillows), U.S. Patent Application 2009 / 0044808 (which describes the Resmed Ltd. SWIFT TM LT nasal pillows); International Patent Applications WO 2005 / 063,328 and WO 2006 / 130,903 (which describe the MIRAGE LIBERTY TM Aspects of the full face mask); International Patent Application WO 2009 / 052,560 (which describes the Resmed Ltd. SWIFT TM Other aspects of the FX pillows).

[0058] Many seal-forming structures of the prior art include an element made of silicone (or another similar polymer) that creates a seal against the patient's face. However, some patients may not like the surface texture of silicone and / or its lack of breathability.

[0059] 1.2.3.1.2 Positioning and stabilization

[0060] The seal-forming structure of the patient interface for positive air pressure therapy is subjected to the corresponding force of the air pressure that will destroy the seal. Therefore, various techniques have been used to position the seal-forming structure and maintain it in a sealing relationship with the appropriate part of the face.

[0061] One technique is to use an adhesive. See, for example, US Patent Application Publication No. US 2010 / 0000534. However, the use of an adhesive may be uncomfortable for some people.

[0062] Another technique is to use one or more straps and / or stabilizing harnesses.Many of these harnesses suffer from one or more of being ill-fitting, bulky, uncomfortable, and inconvenient to use.

[0063] 1.2.3.2 Respiratory Pressure Therapy (RPT) Devices

[0064] Respiratory pressure therapy (RPT) devices can be used alone or as part of a system to deliver one or more of the various therapies described above, for example by operating the device to generate an air flow for delivery to an airway interface. The air flow can be pressure controlled (for respiratory pressure therapy) or flow controlled (for flow therapy such as HFT). Thus, RPT devices can also be used as flow therapy devices. Examples of RPT devices include CPAP devices and ventilators.

[0065] 1.2.3.3 Air circuit

[0066] An air circuit is a conduit or tube that is constructed and arranged to allow, in use, air flow to travel between two components of a respiratory therapy system such as an RPT device and a patient interface. In some cases, there may be separate branches of the air circuit for inspiration and exhalation. In other cases, a single branch air circuit is used for inspiration and exhalation.

[0067] 1.2.3.4 Humidifier

[0068] Delivering an air stream without humidification can result in airway drying. Using a humidifier with an RPT device and a patient interface to produce humidified gas minimizes drying of the nasal mucosa and increases patient airway comfort. Additionally, in colder climates, warm air, which is often applied to the facial area in and around the patient interface, is more comfortable than cold air. Therefore, a humidifier typically has the ability to heat the air stream as well as humidify it.

[0069] 1.2.3.5 Oxygen source

[0070] Experts in the field have recognized that exercise for patients with respiratory failure provides long-term benefits, which slows the progression of the disease, improves quality of life and prolongs the life of patients. However, most fixed forms of exercise, such as treadmills and stationary bicycles, are too strenuous for these patients. As a result, the need for mobility has long been recognized. Until recently, such mobility has been facilitated by the use of small compressed oxygen tanks or cylinders mounted on carts with small wheels. The disadvantages of these tanks are that they contain a limited amount of oxygen and are heavy, weighing about 50 pounds when mounted.

[0071] Oxygen concentrators have been used for about 50 years to provide oxygen for respiratory therapy. Traditional oxygen concentrators are large and cumbersome, making them difficult and impractical for ordinary mobile activities. Recently, companies that manufacture large, fixed oxygen concentrators have begun to develop portable oxygen concentrators (POCs). The advantage of POCs is that they can produce a theoretically unlimited supply of oxygen. In order to make these devices less mobile, the various systems used to produce oxygen-enriched gas need to be condensed. POCs seek to use the oxygen they produce as efficiently as possible to minimize weight, size, and power consumption. This can be achieved by delivering oxygen in a series of pulses or "boli", with each boli timed to coincide with the start of inspiration. This mode of therapy is called pulsed or on-demand (oxygen) delivery (POD), as opposed to traditional continuous flow delivery that is more suitable for fixed oxygen concentrators.

[0072] 1.2.3.6 Data Management

[0073] There may be many clinical reasons to obtain data to determine whether a patient being treated with a prescribed respiratory therapy is "compliant," such as if the patient has used their RPT device in accordance with one or more "compliance rules." One example of a compliance rule for CPAP therapy is a requirement that the patient use the RPT device for at least four hours each night for at least 21 or 30 consecutive days in order for the patient to be considered compliant. To determine the patient's compliance, a provider of the RPT device, such as a healthcare provider, may manually obtain data describing the use of the RPT device for the patient's treatment, calculate the use over a predetermined time period and compare to the compliance rules. Once the healthcare provider has determined that the patient has used their RPT device in accordance with the compliance rules, the healthcare provider may inform the patient of the third part of compliance.

[0074] There are other aspects of patient treatment that may benefit from the communication of treatment data to third parties or external systems.

[0075] Existing methods of communicating and managing such data can be one or more of the following: expensive, time consuming, and error prone.

[0076] 1.2.3.7 Ventilation technology

[0077] Some forms of therapy systems may include a vent to allow flushing of exhaled carbon dioxide. The vent may allow gas to flow from an interior space of the patient interface (eg, a plenum) to a space outside the patient interface, such as to the environment.

[0078] The vent may include an orifice through which gas may flow when the mask is in use. Many such vents are noisy. Others may become blocked during use, thereby providing insufficient flushing. Some vents may disturb the sleep of the patient's 1000 bed partner 1100, for example, by making noise or by gathering airflow.

[0079] Resmed Limited has developed many improved mask ventilation technologies. See International Patent Application Publication No. WO 1998 / 034,665; and International Patent Application Publication No. WO 2000 / 078,381; U.S. Patent No. 6,581,594; U.S. Patent Application Publication No. US 2009 / 0050156; and U.S. Patent Application Publication No. 2009 / 0044808.

[0080] Noise table of existing masks (ISO 17510-2:2007, 10cmH at 1m) 2 O pressure)

[0081] Mask Name Mask Type A-weighted sound power level dB(A) (uncertainty) A-weighted sound pressure dB(A) (uncertainty) Year (approximately) Glue-on (*) nose 50.9 42.9 1981 ResCare standard (*) nose 31.5 23.5 1993 <![CDATA[ResMed Mirage TM (*)]]> nose 29.5 21.5 1998 <![CDATA[ResMed UltraMirage TM > nose 36 (3) 28 (3) 2000 <![CDATA[ResMed Mirage Activa TM > nose 32 (3) 24 (3) 2002 <![CDATA[ResMed Mirage Micro TM > nose 30 (3) 22 (3) 2008 <![CDATA[ResMed Mirage TM SoftGel]]> nose 29 (3) 22 (3) 2008 <![CDATA[ResMed Mirage TM FX]]> nose 26 (3) 18 (3) 2010 <![CDATA[ResMed Mirage Swift TM (*)]]> Nasal pillows 37 29 2004 <![CDATA[ResMed Mirage Swift TM II]]> Nasal pillows 28 (3) 20 (3) 2005 <![CDATA[ResMed Mirage Swift TM LT]]> Nasal pillows 25 (3) 17 (3) 2008 ResMed AirFit P10 Nasal pillows 21 (3) 13 (3) 2014

[0082] (One sample only, using the test method specified in ISO 3744 in CPAP mode at 10 cmH 2 O).

[0083] The sound pressure values ​​for various objects are listed below

[0084] Object A-weighted sound pressure dB (A) Note Vacuum cleaner: Nilfisk Walter Broadly Litter Hog: Grade B+ 68 ISO 3744, distance 1 m Conversational Voice 60 Distance 1 m Average home 50 Quiet library 40 Quiet bedroom at night 30 TV studio background 20

[0085] 1.2.4 Screening, diagnosis and surveillance systems

[0086] Polysomnography (PSG) is a conventional system for diagnosing and monitoring cardiopulmonary diseases, and usually involves clinical experts to apply the system. PSG usually involves placing 15 to 20 contact sensors on the patient to record various body signals, such as electroencephalogram (EEG), electrocardiogram (ECG), electrooculogram (EOG), electromyogram (EMG), etc. PSG for sleep-disordered breathing involves observing the patient in the clinic for two nights, one night for pure diagnosis and the second night for the clinician to titrate the treatment parameters. Therefore, PSG is expensive and inconvenient. In particular, it is not suitable for home screening / diagnosis / monitoring of sleep-disordered breathing.

[0087] Screening and diagnosis generally describe the identification of a condition from its signs and symptoms. Screening typically gives a true / false result indicating whether a patient's SDB is severe enough to warrant further investigation, while diagnosis can yield clinically actionable information. Screening and diagnosis tend to be one-time processes, while monitoring the progression of a condition can continue indefinitely. Some screening / diagnosis systems are only for screening / diagnosis, while some can also be used for monitoring.

[0088] A clinical expert may be able to adequately screen, diagnose, or monitor a patient based on visually observed PSG signals. However, there are situations where a clinical expert may not be available or may not be affordable. Different clinical experts may disagree on a patient's condition. Furthermore, a given clinical expert may apply different criteria at different times. Summary of the invention

[0089] The present technology is intended to provide a medical device for screening, diagnosing, monitoring, ameliorating, treating or preventing respiratory disorders with improved one or more of comfort, cost, efficacy, ease of use and manufacturability.

[0090] A first aspect of the present technology relates to a device for screening, diagnosing, monitoring, ameliorating, treating or preventing a respiratory disorder.

[0091] Another aspect of the present technology relates to methods for screening, diagnosing, monitoring, ameliorating, treating or preventing breathing disorders.

[0092] One aspect of some forms of the present technology is for providing methods and / or apparatus for improving patient compliance with respiratory therapy.

[0093] Another aspect of one form of the present technology is to provide a patient interface that is capable of bending to accommodate patients with faces of varying widths.

[0094] Another aspect of one form of the present technology is to provide a lightweight oral-nasal patient interface.

[0095] Another aspect of one form of the present technology is to provide a comfortable and low-cost oral-nasal patient interface.

[0096] Another form of the present technology includes a patient interface, the patient interface including:

[0097] a frame formed of a flexible material and partially forming a plenum chamber pressurizable to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, the frame including a channel around a perimeter of the frame, the plenum chamber having at least one plenum chamber inlet port, the at least one plenum chamber inlet port being sized and configured to receive a flow of air at the therapeutic pressure for breathing by a patient;

[0098] at least one pair of headband connections connected to the frame;

[0099] a seal-forming structure releasably connectable to the frame and partially forming a plenum chamber, the seal-forming structure being constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, the seal-forming structure having at least one aperture therein so that a flow of air at a therapeutic pressure is delivered to the patient's nostrils and to an entrance to the patient's mouth, the seal-forming structure being constructed and arranged, in use, to maintain said therapeutic pressure in the plenum chamber throughout a breathing cycle of the patient,

[0100] wherein the seal-forming structure comprises a foam lower cushion and a membrane portion, the membrane portion being connected to the foam lower cushion and configured to be inflated in use to form a seal against at least the nasal prominence area and the ala of the nose of the patient, the seal-forming structure being further configured to form a seal around the patient's mouth;

[0101] wherein the foam underpad of the seal-forming structure includes a connecting portion on a non-patient-facing side of the foam underpad, the connecting portion being configured to be received in the channel of the frame to releasably connect the seal-forming structure to the frame.

[0102] In the example:

[0103] •The frame is formed of an elastomeric material;

[0104] •The frame is formed of silicone;

[0105] • The silicone forming the frame has a hardness of 40 Shore A;

[0106] •The channel extends around the entire perimeter of the frame;

[0107] • Channels and foam underpads engage to create a seal;

[0108] • the foam lower pad forms a convex portion configured for engagement with a concave portion of the frame;

[0109] • the channel has a substantially C-shaped cross-section;

[0110] • the channel opens outwardly relative to the frame, and the connecting portion of the foam lower pad includes an opening having a perimeter facing inwardly relative to the opening, the perimeter of the opening being configured to fit within the channel;

[0111] •The connecting portion is configured to be press-fit into the channel;

[0112] • the foam underpad is formed of a polyurethane, such as a thermoplastic polyurethane;

[0113] •The foam underpad is formed of a thermoplastic elastomer;

[0114] • a foam underpad configured to hold the membrane portion substantially taut when the patient interface is not in use;

[0115] • the membrane portion is connected to the foam underpad around the outer perimeter of the membrane portion;

[0116] • Bonding the membrane portion to the foam underpad;

[0117] • the membrane portion comprises a first aperture through which air can flow to both nostrils of a patient in use;

[0118] • the membrane portion is configured to be stretched by the patient's nose adjacent the first aperture in use;

[0119] • the membrane portion comprises a second aperture through which air can flow to the patient's mouth in use;

[0120] • the membrane portion is at least partially formed from a textile material;

[0121] • the fabric material forms a patient-facing side of the membrane portion, and the membrane portion further comprises a gas impermeable coating on a non-patient-facing side thereof;

[0122] •The air-impermeable coating contains a silicone layer;

[0123] • the silicone layer has a thickness in the range of 0.02 mm-0.05 mm;

[0124] • The total thickness of the membrane portion is approximately 0.3 mm; and / or

[0125] •The membrane portion is formed from a single sheet.

[0126] In a further example:

[0127] • the foam lower cushion includes a nasal portion configured to be positioned proximate a lower periphery of a patient's nose in use, the foam lower cushion including a nasal recess located in the nasal portion, the nasal recess configured to prevent the seal-forming structure from obstructing the patient's nose;

[0128] • the nasal recess comprises a shape corresponding to the lower periphery of the patient's nose; and / or

[0129] •The membrane portion is connected to the foam under-cushion around the perimeter of the nasal recess.

[0130] In a further example:

[0131] • the frame has a non-zero negative first principal curvature and a second principal curvature that is less than the first principal curvature;

[0132] • the second principal curvature is substantially zero and, in use, is substantially parallel to the sagittal plane of the patient;

[0133] • the frame is curved so that when worn by a patient with a narrow face, the first principal curvature has a greater magnitude than when worn by a patient with a relatively wider face;

[0134] • at least one pair of headband connector portions including a pair of upper headband connector portions connected to the frame and a pair of lower headband connector portions connected to the frame;

[0135] • Each upper headband connector portion includes a flex arm; and / or

[0136] •Each lower headband connector section contains a magnetic connector.

[0137] Another form of the present technology includes a patient interface, the patient interface including:

[0138] a frame that partially forms a plenum chamber that is pressurizable to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, the plenum chamber having at least one plenum chamber inlet port that is sized and configured to receive a flow of air at the therapeutic pressure for patient breathing,

[0139] at least one pair of headband connectors connected to the frame;

[0140] a seal-forming structure connected to the frame and partially forming a plenum chamber, the seal-forming structure being constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, the seal-forming structure having at least one aperture therein so that a flow of air at a therapeutic pressure is delivered to the patient's nostrils and the entrance to the patient's mouth, the seal-forming structure being constructed and arranged, in use, to maintain said therapeutic pressure in the plenum chamber throughout the patient's breathing cycle,

[0141] wherein the seal-forming structure comprises a lower cushion and a membrane portion, the membrane portion being connected to the lower cushion and configured to be inflated in use to form a seal against at least the nasal prominence area and the nasal wings of the patient's nose, the seal-forming structure being further configured to form a seal around the patient's mouth;

[0142] The lower cushion includes a nasal portion, the nasal portion is configured to be positioned adjacent to a lower periphery of a patient's nose during use, the lower cushion includes a nasal recess in the nasal portion, the nasal recess includes an inwardly facing wall, the inwardly facing wall is configured to face and at least partially surround the lower periphery of the patient's nose during use, and the membrane portion is supported by the lower cushion at the periphery of the nasal recess.

[0143] In the example:

[0144] • The nasal recess is configured to avoid engaging both lateral sides of the patient's nose simultaneously;

[0145] • the nasal recess is configured to provide substantially no medially directed force on the nasal ala of the patient in use;

[0146] • the nasal recess is constructed and arranged so that in use the lower cushion exerts substantially no force on the patient's nose;

[0147] • the nasal recess is configured to prevent the seal-forming structure from obstructing the patient's nose during use;

[0148] •The nasal concave portion comprises a shape corresponding to the lower periphery of the patient's nose;

[0149] • In use, the nasal recess surrounds substantially all of the lateral and forward facing portions of the lower periphery of the patient's nose;

[0150] • an inwardly facing wall extending from about one cheek of the patient around the patient's nose to about the other cheek of the patient;

[0151] •Attach the membrane portion around the perimeter of the nasal recess to the foam underpad;

[0152] • the lower cushion comprises an upwardly facing surface, the upwardly facing surface being disposed adjacent to and around a perimeter of the nasal recess, the membrane portion being connected to the upwardly facing surface of the lower cushion;

[0153] • the inwardly facing wall has a concave cross-section in a horizontal plane parallel to the Frankfurt horizontal plane of the patient's head;

[0154] •The inward-facing wall has a concave cross-section in the sagittal plane and / or in a vertical plane parallel to the coronal plane;

[0155] • the lower cushion includes a pair of posterior support portions, each posterior support portion being positioned on a respective lateral side of the nasal recess and configured to engage the patient's face midway and proximal to the nasolabial grooves of the patient's face;

[0156] • the rear support portion engages the patient's face at a location below the ala of the nose on either side above the patient's lips and / or at a location vertically aligned with the patient's ala of the nose between the ala of the nose and the nasolabial groove;

[0157] • the rear support portion is shaped to project at least partially centrally into a depression formed on the patient's face on either lateral side of the patient's nose; and / or

[0158] • The inward-facing wall extends from a first one of the rear support sections around the patient's nose to another one of the rear support sections.

[0159] In a further example:

[0160] • the seal-forming structure is releasably connected to the frame;

[0161] • the frame includes a channel around a perimeter of the frame, and a lower cushion of the seal-forming structure includes a connecting portion on a side of the lower cushion that does not face the patient, the connecting portion being configured to be received in the channel of the frame to releasably connect the seal-forming structure to the frame;

[0162] •The channel extends around the entire perimeter of the frame;

[0163] •The channel and lower gasket engage to form a seal;

[0164] • the lower gasket forms a convex portion configured for engagement with a concave portion of the frame;

[0165] • the channel has a substantially C-shaped cross-section;

[0166] • the channel opens outwardly relative to the frame, and the connecting portion of the lower cushion includes an opening having a perimeter facing inwardly relative to the opening, the perimeter of the opening being configured to fit within the channel;

[0167] •The connecting portion is configured to be press-fit into the channel;

[0168] • the lower cushion is configured to hold the membrane portion substantially taut when the patient interface is not in use;

[0169] • the membrane portion is connected to the lower liner around the outer periphery of the membrane portion;

[0170] • Bonding the membrane portion to the lower liner;

[0171] • the membrane portion comprises a first aperture through which air can flow to both nostrils of a patient in use;

[0172] • the membrane portion is configured to be stretched by the patient's nose adjacent the first aperture in use;

[0173] • the membrane portion comprises a second aperture through which air can flow to the patient's mouth in use;

[0174] • the membrane portion is at least partially formed from a textile material;

[0175] • the fabric material forms a patient-facing side of the membrane portion, and the membrane portion further comprises a gas impermeable coating on a non-patient-facing side thereof;

[0176] •The air-impermeable coating contains a silicone layer;

[0177] • the silicone layer has a thickness in the range of 0.02 mm-0.05 mm;

[0178] • The total thickness of the membrane portion is approximately 0.3 mm; and / or

[0179] •The membrane portion is formed from a single sheet.

[0180] •The lower padding is formed of foam;

[0181] • the foam underpad is formed of a polyurethane, such as a thermoplastic polyurethane;

[0182] •The foam underpad is formed of a thermoplastic elastomer;

[0183] •The frame is made of flexible material;

[0184] •The frame is formed of silicone;

[0185] • The silicone forming the frame has a hardness of 40 Shore A durometer;

[0186] •The channel extends around the entire perimeter of the frame;

[0187] • the frame has a non-zero negative first principal curvature and a second principal curvature that is less than the first principal curvature;

[0188] • the second principal curvature is substantially zero and, in use, is substantially parallel to the sagittal plane of the patient;

[0189] • the frame is curved so that when worn by a patient with a narrow face, the first principal curvature has a greater magnitude than when worn by a patient with a relatively wider face;

[0190] • at least one pair of headband connectors including a pair of upper headband connectors connected to the frame and a pair of lower headband connectors connected to the frame;

[0191] • Each upper headband connector includes a flex arm; and / or

[0192] •Each lower headband connector contains a magnetic connector.

[0193] Another aspect of one form of the present technology is a patient interface that is molded or otherwise configured to have a peripheral shape that is complementary to the peripheral shape of the intended wearer.

[0194] One aspect of one form of the present technology is a method of making a device.

[0195] One aspect of some forms of the present technology is an easy to use medical device, for example for a person with no medical training, a person with clumsiness, limited vision or a person with limited experience in using this type of medical device.

[0196] One aspect of one form of the present technology is a portable RPT device that can be carried by a person (e.g., a person in a person's home).

[0197] One aspect of one form of the present technology is a patient interface that can be cleaned at the patient's home, e.g., in soapy water, without the need for specialized cleaning equipment. One aspect of one form of the present technology is a humidifier canister that can be cleaned at the patient's home, e.g., in soapy water, without the need for specialized cleaning equipment.

[0198] The described methods, systems, devices and apparatus may be implemented to improve the functionality of a processor, such as a processor of a dedicated computer, a respiratory monitor and / or a respiratory therapy device. In addition, the described methods, systems, devices and apparatus may provide improvements in the art of automated management, monitoring and / or treatment of respiratory conditions, including, for example, sleep-disordered breathing.

[0199] Of course, a part of these aspects may form a sub-aspect of the present technology. Each aspect and / or each of the aspects may be combined in various ways and also constitute other aspects or sub-aspects of the present technology.

[0200] Other features of the present technology will become apparent from consideration of the information contained in the following detailed description, abstract, drawings, and claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0201] The present technology is illustrated by way of example and not limitation in the figures of the accompanying drawings in which like reference numerals refer to like elements, including:

[0202] 3.1 Respiratory therapy system

[0203] Figure 1A A system is shown that includes a patient 1000 wearing a patient interface 3000 in the form of nasal pillows receiving a supply of air at a positive pressure from a RPT device 4000. Air from the RPT device 4000 is conditioned in a humidifier 5000 and delivered along an air circuit 4170 to the patient 1000. A bed partner 1100 is also shown. The patient sleeps in a supine sleeping position.

[0204] Figure 1B A system is shown that includes a patient 1000 wearing a patient interface 3000 in the manner of a nasal mask receiving a supply of air at a positive pressure from an RPT device 4000. Air from the RPT device is humidified in a humidifier 5000 and delivered to the patient 1000 along an air circuit 4170.

[0205] Figure 1C A system is shown that includes a patient 1000 wearing a patient interface 3000 in the form of a full face mask receiving a supply of air under positive pressure from an RPT device 4000. Air from the RPT device is humidified in a humidifier 5000 and delivered to the patient 1000 along an air circuit 4170. The patient sleeps in a side-lying sleeping position.

[0206] 3.2 Respiratory system and facial anatomy

[0207] Figure 2A Shown is a schematic diagram of the human respiratory system including the nasal and oral chambers, larynx, vocal cords, esophagus, trachea, bronchi, lungs, alveolar sacs, heart, and diaphragm.

[0208] Figure 2B A view of the human upper airway including the nasal chamber, nasal bones, external nasal cartilages, greater alar cartilages, nostrils, upper lip, lower lip, larynx, hard palate, soft palate, oropharynx, tongue, epiglottis, vocal cords, esophagus, and trachea is shown.

[0209] Figure 2C is a front view of the face with several surface anatomical features labeled, including the upper lip, upper lip vermilion, lower lip vermilion, lower lip, mouth width, medial canthus, nasal wing, nasolabial fold, and corner of mouth. The superior, inferior, radially inward, and radially outward directions are also labeled.

[0210] Figure 2D It is a side view of the head with several surface anatomical features labeled, including the glabella, nasal bridge point, nasal prominence point, subnasal septum point, upper lip, lower lip, supramental point, nasal ridge, nasal apex, supra-auricular base point, and subauricular base point. The superior-inferior and anterior-posterior directions are also labeled.

[0211] Figure 2EThis is another lateral view of the head. The approximate location of the Frankfort horizontal plane and the nasolabial angle are indicated. The coronal plane is also indicated.

[0212] Figure 2F A bottom view of the nose is shown with several features identified, including the nasolabial folds, lower lip, vermillion, nostrils, subseptal point, columella, nasal process point, long axis of the nostrils, and midsagittal plane.

[0213] Figure 2G A side view of the nasal surface features is shown.

[0214] Figure 2H The subcutaneous structures of the nose are shown, including the lateral cartilage, septal cartilage, greater alar cartilage, lesser alar cartilage, sesamoid cartilage, nasal bone, epidermis, adipose tissue, frontal process of the maxilla, and fibroadipose tissue.

[0215] Fig.2I The medial anatomy of the nose is shown approximately a few millimeters from the mid-sagittal plane, showing, among other things, the medial crus of the septal cartilage and the greater alar cartilage.

[0216] Figure 2J A front view of the skull is shown, including the frontal, nasal, and zygomatic bones. The nasal turbinates are also indicated, as well as the maxilla and mandible.

[0217] Figure 2K A side view of the skull with the outline of the head surface and several muscles is shown. The following bones are shown: frontal, sphenoid, nasal, zygomatic, maxillary, mandibular, parietal, temporal, and occipital. The mental protuberance is also labeled. The following muscles are shown: digastric, masseter, sternocleidomastoid, and trapezius.

[0218] Figure 2L An anterolateral view of the nose is shown.

[0219] 3.3 Patient Interface

[0220] Figure 3A A patient interface in the form of a nasal mask is shown in accordance with one form of the present technology.

[0221] Figure 3B A schematic diagram of a cross section through the structure at a point is shown. The outward normal at point is indicated. The curvature at this point has a positive sign and is Figure 3C The curvature magnitude shown is relatively large in comparison.

[0222] Figure 3C A schematic diagram of a cross section through the structure at a point is shown. The outward normal at point is indicated. The curvature at this point has a positive sign and is Figure 3B The curvature magnitude shown is relatively small in comparison.

[0223] Figure 3D A schematic diagram of a cross section through the structure at a point is shown. The outward normal at point is indicated. The curvature at point has a value of zero.

[0224] Figure 3E A schematic diagram of a section through the structure at a point is shown. The outward normal at point is indicated. The curvature at this point has a negative sign and is Figure 3F The curvature magnitude shown is relatively small in comparison.

[0225] Figure 3F A schematic diagram of a cross section through the structure at a point is shown. The outward normal at point is indicated. The curvature at this point has a negative sign and is Figure 3E The curvature magnitude shown is relatively large in comparison.

[0226] Figure 3G A cushion for a mask comprising two pillows is shown. The outer surface of the cushion is indicated. The edges of the surface are shown. The dome and saddle areas are shown.

[0227] Figure 3H A cushion for a mask is shown. The outer surface of the cushion is indicated. The edge of the surface is shown. The path on the surface between points A and B is indicated. The straight-line distance between A and B is indicated. Two saddle areas and one dome area are indicated.

[0228] Fig. 3I A surface having a structure with a one-dimensional hole on the surface is shown. The plane curves shown form the boundaries of the one-dimensional hole.

[0229] Figure 3J Shown through Fig. 3I The surface shown is in Fig. 3I A two-dimensional hole is defined in the structure.

[0230] Figure 3K Shows Fig. 3I A perspective view of the structure of includes two-dimensional holes and one-dimensional holes. Also shown is the Fig. 3I The surface of the two-dimensional holes is defined in the structure.

[0231] Figure 3L A mask with an inflatable bladder as cushion is shown.

[0232] Figure 3M Shown through Figure 3L A cross section of a mask of FIG. 1 and showing the inner surface of the airbag. The inner surface defines a two-dimensional hole in the mask.

[0233] Figure 3N Shown by Figure 3LAnother cross section of the mask. The inner surface is also indicated.

[0234] Fig.3O The left hand rule is shown.

[0235] Figure 3P The right hand rule is shown.

[0236] Figure 3Q The left ear is shown, including the left ear helix.

[0237] Figure 3R The right ear is shown, including the right ear helix.

[0238] Figure 3S A right-hand helix is ​​shown.

[0239] Figure 3T Views of a mask are shown including symbols for the twisting of the spatial curve defined by the edge of the sealing membrane in different regions of the mask.

[0240] Figure 3U A view of the plenum chamber 3200 is shown, showing the sagittal plane and the medial contact plane.

[0241] Figure 3V Shows Figure 3U A view of the rear portion of the plenum chamber. The view is oriented perpendicular to the median contact plane. Figure 3V The sagittal plane divides the air chamber into two equal parts: left and right sides.

[0242] Figure 3W Shown through Figure 3V The cross section of the gas-filled chamber is Figure 3V 32. The middle contact plane is perpendicular to the sagittal plane. The orientation of the middle contact plane corresponds to the orientation of the chord 3210, which lies in the sagittal plane and contacts the cushion of the plenum chamber at two points just above the sagittal plane: the upper point 3220 and the lower point 3230. Depending on the geometry of the cushion in this area, the middle contact plane may be a tangent at the upper and lower points.

[0243] Figure 3X Shows Figure 3U The inflatable chamber 3200 is in the position of use on the face. When the inflatable chamber is in the use position, the sagittal plane of the inflatable chamber 3200 substantially coincides with the mid-sagittal plane of the face. When the inflatable chamber is in the use position, the middle contact plane generally corresponds to the 'facial plane'. Figure 3X In FIG. 3 , the inflation chamber 3200 is the inflation chamber of the nasal mask, and the upper point 3220 is approximately located on the root of the nose, while the lower point 3230 is located on the upper lip.

[0244] Figure 3Y shows a patient interface in the form of a nasal cannula in accordance with one form of the present technology.

[0245] 3.4RPT device

[0246] Figure 4A One form of RPT device according to the present technology is shown.

[0247] Figure 4B is a schematic diagram of the pneumatic path of an RPT device in accordance with one form of the present technology. Upstream and downstream directions are indicated with reference to a blower and a patient interface. The blower is defined as upstream of the patient interface and the patient interface is defined as downstream of the blower, regardless of the actual flow direction at any particular moment. Items within the pneumatic path between the blower and the patient interface are downstream of the blower and upstream of the patient interface.

[0248] 3.5 Humidifier

[0249] Figure 5A An isometric view of a humidifier according to one form of the present technology is shown.

[0250] Figure 5B An isometric view of a humidifier according to one form of the present technology is shown showing the humidifier reservoir 5110 removed from the humidifier reservoir base 5130.

[0251] 3.6 Respiratory waveform

[0252] Fig. 6A A model typical breathing waveform of a person during sleep is shown.

[0253] 3.7 Patient Interface of the Technology

[0254] Figure 7 A perspective view of a patient interface in accordance with one form of the present technology is shown.

[0255] Figure 8 yes Figure 7 Exploded perspective view of the patient interface.

[0256] Fig. 9 yes Figure 7 A perspective view of a framework of a patient interface.

[0257] Fig.10 yes Figure 7 Rear-superior view of the patient interface.

[0258] Fig.11 yes Figure 7 Superoposterior view of the lower pad of the patient interface.

[0259] Fig.12 yes Figure 7A top view of a lower cushion of a patient interface detached and held near a use position but held just off the surface of the patient's face to illustrate the relationship between the shape of the lower cushion and the shape of the patient's face.

[0260] Fig.13 yes Figure 7 Detail view of the patient interface in the use position.

[0261] Fig.14 is a schematic diagram of a framework according to one form of the technology.

[0262] Fig.15 It is worn by the patient Figure 7 A side view of a patient interface and showing one side of the positioning and stabilizing structure.

[0263] Fig.16 yes Figure 7 View of the patient contacting side of the patient interface.

[0264] Fig.17 yes Figure 7 Detailed view of the nasal portion of the patient interface.

[0265] Fig.18A is a perspective view of a lower pad according to an example of the present technology.

[0266] Fig.18B is through Fig.18A A cross-sectional view of the nasal portion of the lower cushion is shown.

[0267] Fig.19A is a perspective view of a lower pad according to an example of the present technology.

[0268] Fig.19B is through Fig.19B A cross-sectional view of the nasal portion of the lower cushion is shown.

[0269] Fig.19C is with Fig.19B A cross-sectional view through the nasal portion of another lower cushion according to an example of the present technology at the same location as the cross-section shown. DETAILED DESCRIPTION

[0270] Before further describing the present technology in detail, it should be understood that the present technology is not limited to the specific examples described herein, and the specific examples described herein may be changed. It should also be understood that the terms used in the present invention are only used for the purpose of describing the specific examples discussed herein, and are not intended to be limiting.

[0271] The following description is provided in relation to various examples that may share one or more common features and / or characteristics. It should be understood that one or more features of any one example may be combined with one or more features of another example or other examples. In addition, in any one of the examples, any single feature or combination of features may constitute another example.

[0272] 4.1 Treatment

[0273] In one form, the present technology includes a method for treating a breathing disorder comprising applying positive pressure to an airway entrance of a patient 1000 .

[0274] In certain examples of the present technology, a supply of air under positive pressure is provided to the patient's nasal passages via one or both nostrils.

[0275] In certain examples of the present technology, mouth breathing is limited, restricted or prevented.

[0276] 4.2 Respiratory therapy system

[0277] In one form, the present technology includes a respiratory therapy system for treating a respiratory disorder. The respiratory therapy system may include an RPT device 4000 for supplying an air flow to a patient 1000 via an air circuit 4170 and a patient interface 3000 or 3800 .

[0278] 4.3 Patient Interface

[0279] A non-invasive patient interface 3000 according to one aspect of the present technology includes the following functional aspects: a seal-forming structure 3100, an inflatable chamber 3200, a positioning and stabilizing structure 3300, a vent 3400, a connection port 3600 for connecting to a form of air circuit 4170, and a forehead support 3700 in some particular instances. In some forms, the functional aspects may be provided by one or more physical components. In some forms, one physical component may provide one or more functional aspects. In use, the seal-forming structure 3100 is arranged to surround the entrance of the patient's airway so as to maintain a positive pressure at the entrance of the airway of the patient 1000. The sealed patient interface 3000 is therefore suitable for the delivery of positive pressure therapy.

[0280] If a patient interface cannot comfortably deliver a minimum level of positive pressure to the airway, the patient interface may not be suitable for respiratory pressure therapy.

[0281] A patient interface 3000 according to one form of the present technology is constructed and arranged to be capable of moving at a relative speed of at least 6 cm H relative to the environment. 2 O positive pressure supply air.

[0282] A patient interface 3000 according to one form of the present technology is constructed and arranged to be capable of moving at least 10 cm H relative to the environment.2 O positive pressure supply air.

[0283] A patient interface 3000 according to one form of the present technology is constructed and arranged to be capable of moving at least 20 cm H relative to the environment. 2 O, for example up to 30 cmH 2 O or up to 40 cmH 2 O positive pressure supply air.

[0284] Figure 7-13 15-17 show various views of a patient interface 3000 according to an example of the present technology. In this example, the patient interface 3000 includes a frame 3240 that partially forms a plenum chamber 3200 that can be pressurized to a therapeutic pressure that is at least 6 cmH2O above ambient air pressure. The plenum chamber 3200 has at least one plenum chamber inlet port 3202 that is sized and structured to receive a flow of air at a therapeutic pressure for patient breathing.

[0285] The patient interface 3000 may also include at least one pair of headgear connectors connected to the frame 3240. In the illustrated example, the patient interface 3000 includes a pair of upper headgear connector portions 3310 and a pair of lower headgear connector portions 3320. In other examples, there may be only one pair of headgear connectors (e.g., a two-point headgear connection).

[0286] Likewise Figure 7-13 As shown in Figures 15-17, the patient interface 3000 further includes a seal-forming structure 3100, which is connected to the frame 3240 and partially forms the plenum chamber 3200. The seal-forming structure 3100 is constructed and arranged to form a seal with an area of ​​the patient's face surrounding the patient's airway entrance in use. The seal-forming structure 3100 has at least one hole therein so that a flow of air at a therapeutic pressure is delivered to the patient's nostrils and the entrance of the patient's mouth. The seal-forming structure 3100 is constructed and arranged to maintain the therapeutic pressure in the plenum chamber throughout the patient's breathing cycle in use.

[0287] In some examples of the present technology, the seal-forming structure 3100 includes a lower cushion 3225. The seal-forming structure 3100 may also include a membrane portion 3220 connected to the lower cushion 3225, the membrane portion being configured to expand when in use to form a seal against at least the anterior nasal region and the nasal ala of the patient's nose. In this example, the seal-forming structure 3100 is further configured to form a seal around the patient's oral cavity.

[0288] exist Figure 7-1315-17 and in other examples, the lower cushion 3225 and the membrane 3220 can together form a cushion module. The cushion module can be combined with other components, such as the frame 3240, the positioning and stabilizing structure 3300 (e.g., headband), and the connector 3620 and / or the short tube 3610 for fluid connection to the air circuit to form the patient interface 3000. The cushion module, and therefore the lower cushion 3225 and the membrane 3220, can be provided in a variety of shape / size options to fit a range of patient facial shapes and sizes.

[0289] 4.3.1 Inflatable chamber

[0290] In the area where the seal is formed in use, the plenum 3200 has a perimeter shaped to complement the surface contour of an average human face. In use, the boundary edge of the plenum 3200 is positioned in close proximity to the adjacent surface of the face. Actual contact with the face is provided by the seal-forming structure 3100. The seal-forming structure 3100 may extend along the entire perimeter of the plenum 3200 in use.

[0291] exist Figure 7-13 15-17, the plenum chamber 3200 is formed in part by the seal-forming structure 3100 and in part by the frame 3240. The plenum chamber inlet 3202 in this example is a single opening provided in the frame 3240. In particular, a short tube 3610 is connected to the frame 3240 and fluidly connected to the plenum chamber inlet 3202 to deliver air flow to the plenum chamber 3200. The patient interface 3000 includes a connector 3620 that connects the short tube 3610 to the frame 3240.

[0292] 4.3.2 Framework

[0293] In one form of the technology, the frame 3240 is flexible and can be formed of a flexible material. In some instances, the frame 3240 is formed of an elastomeric material, such as silicone or a thermoplastic elastomer (TPE). In one instance, the frame 3240 can be formed of silicone having a 40 Shore A durometer hardness. Other suitable materials can be used. In some instances, the frame can be formed of Mylar, for example. In one instance, the frame 3240 can be formed of silicone and can have a wall thickness of 2 mm. In other instances, the frame 3240 is substantially rigid and can be formed of a substantially rigid material (such as polycarbonate), or has a structure that imparts substantially rigidity.

[0294] In some examples, the frame 3240 includes a non-zero negative first principal curvature and a second principal curvature that is less than the first principal curvature. In an example, the frame 3240 is curved so that it has a non-zero negative first principal curvature P1 and a substantially zero second principal curvature P2, such as Fig.14 shown.

[0295] In an example, the patient interface is configured such that the second principal curvature P2 is substantially parallel to a sagittal plane of the patient in use and may lie in the sagittal plane in use.

[0296] In some examples, the frame 3240 is formed to be substantially flat but is held in a curved configuration by the seal-forming structure 3100. In other examples, the frame 3240 may be inherently curved, for example, it may be molded or otherwise manufactured to have an inherent curvature. In some examples, the frame 3240 may be sufficiently flexible so that, despite being held in a curved configuration by the lower cushion 3225, the frame 3240 does not substantially deform the lower cushion 3225 (e.g., by a reaction force). In some examples, the lower cushion 3225 holds the frame 3240 in a curved shape that spans the user's face in a transverse-medial direction and allows bending of the curved shape, but substantially prevents bending of the cross-section of the frame 3240 in the sagittal plane.

[0297] The patient interface 3000 may include at least one pair of headgear connectors connected to the frame 3240. The headgear connectors may be configured to connect to headgear straps of the positioning and stabilizing structure 3300 of the patient interface 3000. Figure 7 , 8 As shown in Figures 15 and 15, in some forms of technology, the frame 3240 is provided with a pair of upper headband connector portions 3310 and a pair of lower headband connector portions 3320. In an example, the frame 3240 is also provided with an opening for connecting (e.g., releasably connecting) to an air delivery tube during use. In an example, the frame 3240 is provided with at least one vent 3400 for gas flushing (e.g., providing a continuous flow of gas from the plenum chamber 3200 to the surrounding environment during the patient's breathing cycle during use). Figure 7 and 8 In the example shown, the frame 3240 includes a connector 3620 that provides a connection to a short tube 3610 having a connection port 3600 at its end. The connector 3620 may be in the form of an elbow and / or may be configured to rotate relative to the frame 3240. In this example, a vent 3400 is provided to the connector 3620. The vent 3400 may be formed by a plurality of holes. Fig.15 As shown (only one side is visible), the upper headband connector portion 3310 is connected to the upper headband strap 3311 and the lower headband strap connector portion 3320 is connected to the lower headband strap 3321.

[0298] In instances where the frame 3240 is relatively flexible and has a substantially zero principal curvature that is substantially aligned with the sagittal plane, the frame 3240 can bend relatively easily such that the magnitude of the first principal curvature P1 can be changed when the patient interface 3000 is worn. For example, when the patient interface 3000 is worn by a person with a relatively narrow face, the magnitude of the first principal curvature can be relatively large (e.g., the frame 3240 can be more curved), but when the patient interface 3000 is worn by a person with a relatively wide face, the magnitude of the first principal curvature can be smaller (e.g., the frame 3240 can be relatively "flat"). In such instances, the frame 3240 is configured to be curved such that the first principal curvature has a greater magnitude when worn by a patient with a narrow face than when worn by a patient with a relatively wide face. In this way, the patient interface 3000 can be adapted to fit patients with a range of different sized faces. Forming the frame 3240 using silicone (e.g., 40 Shore A durometer silicone) can provide the above-described bending behavior, even though the frame 3240 includes a C-shaped channel 3250, which, due to its geometry and the resulting effect of the secondary moment of area, increases the stiffness of the frame 3240. The channel 3250 in the frame will be described in the context of the lower pad 3225.

[0299] Because the frame 3240 does not have a pre-formed curvature in the sagittal plane (e.g., the principal curvature P2 described above), the frame 3240 can be configured to be less prone to bending in the sagittal plane (e.g., changing the second principal curvature P2) than in the horizontal plane (e.g., changing the first principal curvature P1). In addition, the frame 3240 is shorter in the superior-inferior direction than in the medial-lateral direction, which further makes the frame 3240 less likely to bend in the sagittal plane. In some examples, the frame 3240 can include a small curvature in the sagittal plane (e.g., the principal curvature P2) by being formed to have a small curvature or by being maintained in a curved shape by the lower pad 3225.

[0300] 4.3.3 Sealing structure

[0301] In one form of the present technology, the seal-forming structure 3100 provides a target seal-forming area and may additionally provide a cushioning function. The target seal-forming area is the area on the seal-forming structure 3100 where sealing is likely to occur. The area where sealing actually occurs - the actual sealing surface - can vary from day to day and from patient to patient within a given course of treatment, depending on a range of factors including, for example, where the patient interface 3000 is placed on the face, the tension in the positioning and stabilizing structure 3300, and the shape of the patient's face.

[0302] In one form, the target seal-forming area is located on an outer surface of the seal-forming structure 3100 .

[0303] In some forms of the present technology, the seal-forming structure 3100 is comprised of a biocompatible material such as silicone rubber.

[0304] The seal-forming structure 3100 according to some examples of the present technology may include a soft, flexible, elastic material, such as silicone.

[0305] In other forms, the seal-forming structure 3100 includes a lower cushion 3225, which may be formed of foam, and a fabric membrane portion 3220, as further described below.

[0306] In certain forms of the present technology, a system is provided that includes more than one seal-forming structure 3100, each seal-forming structure configured to correspond to a different range of sizes and / or shapes. For example, the system may include one form of seal-forming structure 3100 that is suitable for large sized heads but not small sized heads, and another that is suitable for small sized heads but not large sized heads. However, examples of the technology can be suitable for a wide range of heads and therefore can be used by patients with relatively large heads and relatively small heads.

[0307] 4.3.3.1 Lower gasket

[0308] like Figure 7-13 15-17, the seal-forming structure 3100 includes a lower cushion 3225. In the example shown, the lower cushion 3225 is formed of foam, but it should be understood that other materials and structures can also be used to form the lower cushion, such as elastomeric structures, inflatable lower cushions, gels, solid semi-rigid materials, such as silicone or TPE. The lower cushion 3225 is shaped to extend around the patient's mouth and is positioned close to the lower periphery of the patient's nose during use. An example of a patient interface 3000 made according to the present invention can be referred to as an ultra-compact full-face mask.

[0309] Connected to the lower cushion 3225 is a membrane portion 3220 that is configured to contact the patient's face in use to form a seal around the nose and / or mouth, as will be described below. The lower cushion 3225 can hold the membrane portion 3220 in an appropriate position and shape to form a seal against the patient's face. In some instances, the lower cushion 3225 can press the membrane portion 3220 against the user's face around the user's mouth. In some instances, the lower cushion 3225 can support the membrane portion 3220 around the patient's nose so that the membrane portion 3220 engages the patient's nose, but the lower cushion 3225 remains substantially out of contact with the patient's nose, for example to avoid nasal obstruction, as will be described.

[0310] 4.3.3.1.1 Connecting to the framework

[0311] The lower pad 3225 is preferably detachably connected to the frame 3240. In particular, Figure 8 and 9 As shown, the frame 3240 includes a channel 3250 around the periphery of the frame 3240. The lower cushion 3225 can include a connecting portion 3260 on the non-patient-facing side of the lower cushion 3225, and the connecting portion 3260 can be configured to be received in the channel 3250 of the frame 3240 to releasably connect the seal-forming structure 3100 to the frame 3240. When the patient wishes to separate the seal-forming structure 3100 from the frame 3240 (e.g., to clean the seal-forming structure 3100 or replace it), the lower cushion 3225 can be peeled off the frame 3240. The connecting portion 3260 of the lower cushion 3225 can be a portion of the lower cushion 3225 that is shaped corresponding to the channel 3250 in the frame 3240. This connection between the frame 3240 and the lower cushion 3225 can advantageously provide easy connection and disconnection of the frame 3240 and the seal-forming structure 3100.

[0312] In some instances, the channel 3250 can be defined by a front vertical wall, a horizontal wall, and a rear vertical wall. It should be understood that the cross section of the channel 3250 may not necessarily be symmetrical. For example, in such a channel, the front vertical wall and the rear vertical wall do not need to have the same length. In some instances, the front vertical wall of the frame 3240 may be longer than the rear vertical wall. This arrangement may result in the front wall of the frame 3240 covering more of the front outer surface of the lower pad 3225 than the rear wall covering the inner surface of the lower pad 3225.

[0313] In one example, the frame 3240 can be formed of silicone with a 2 mm wall thickness defining the front wall of the frame 3240. The channel 3250 can be formed and defined by three walls of the frame, each having a wall thickness of 2 mm. The inner width of the channel 3250 can be 4 mm. The total cross-sectional thickness of the frame 3240 is approximately 8 mm (including the 2 mm front wall, the inner width of the 4 mm channel 3250, and the 2 mm rear wall). In this example, the connecting portion 3260 of the lower pad 3225 can have a thickness of approximately 5 mm. The foam (or other material, in other examples) forming the connecting portion 3260 can be compressed when assembled to the 4 mm channel 3250, thereby forming a good seal. More generally, the channel 3250 can be smaller than the connecting portion 3260 of the lower pad 3225 to provide an interference fit for an airtight seal.

[0314] The connection between the lower cushion 3225 and the frame 3240 is substantially airtight. That is, a seal is formed between the lower cushion 3225 and the frame 3240 by the engagement between the channel 3250 and the lower cushion 3225. The channel 3250 and the lower cushion 3225 engage to form a seal. The frame 3240 can fit tightly to the lower cushion 3225, which can advantageously create a good air seal, prevent bursting of the foam or other material forming the lower cushion 3225, and transmit headband forces to the lower cushion 3225.

[0315] exist Figure 7-13 In the examples shown in Figures 15-17, the channel 3250 extends around the entire periphery of the frame 3240. The channel 3250 in this example has a C-shaped cross-section, but in other examples, the channel 3250 can include a different cross-section. More generally, the channel 3250 can form a concave connection portion corresponding to the convex connection portion of the lower pad 3225. Figure 7-13 15-17, the channel 3250 is open outwardly relative to the frame, and the connecting portion 3260 of the lower cushion 3225 includes an opening having a perimeter facing inwardly relative to the opening, which is configured to fit within the channel 3250. In this example, the connecting portion 3260 of the lower cushion 3225 is configured to be press-fit into the channel 3250 by the user. In an alternative example, there may be a retaining device such as a clip to secure the lower cushion 3225 in the channel 3250 of the frame 3240.

[0316] Compared to a patient interface 3000 having an underpad with a channel that receives an edge of the frame, the channel 3250 provided to the frame 3240 can advantageously provide a strong and durable connection between the frame 3240 and the underpad 3225. If the channel 3250 is formed in the underpad 3225, it may make the underpad 3225 more susceptible to tearing than it would otherwise be, or may limit the expected useful life of the underpad 3225 more than the above-described arrangements.

[0317] However, in some alternative instances, the lower cushion 3225 is provided with a concave connecting portion (e.g., the channel 3250) and the frame 3240 is provided with a convex portion (e.g., a peripheral edge of the frame 3240) that is configured to be received in the lower cushion 3225, such as if the lower cushion 3225 is made of a sufficiently durable foam, the convex portion having an appropriate geometry (e.g., thickness) and / or having a channel formed from a more durable material.

[0318] In an example, the height, width, and / or depth of the lower cushion may vary between the frame and the fabric membrane portion 3220. That is, the lower cushion 3225 may not have a constant cross-section.

[0319] 4.3.3.1.2 Nasal concave part

[0320] In particular Fig.11 and Fig.12 In one form of the technology shown, the lower cushion 3225 can include a nose portion that is configured to be positioned near the lower periphery of the patient's nose in use, and the lower cushion 3225 includes a nose recess 3228 in the nose portion. The nose recess 3228 can be shaped to receive the patient's nose, and can do so without engaging the user's nose or at least not applying a blocking force to the patient's nose. In some examples, the nose recess 3228 provides a gap between the lower cushion 3225 and the lower periphery of the patient's nose. The nose recess 3228 can be configured to prevent the seal-forming structure 3100 from blocking the patient's nose, such as when the headband is tightened. The membrane portion 3220 can be supported by the lower cushion 3225 at the periphery of the nose recess 3228. For example, the membrane portion 3220 can be connected to the lower cushion 3225 at or near the periphery of the nose recess 3228.

[0321] In some examples, the nasal recess 3228 can space the lower cushion 3225 from the patient's nose, at least when the patient initially puts on the patient interface 3000 before sleep, so as not to press the membrane portion 3220 against the patient's nose, or at least not press the membrane portion 3220 against the wings of the nose. The nasal recess 3228 can prevent the lower cushion 3225 from engaging the patient's nose or at least prevent the lower cushion 3225 from blocking the patient's nose (e.g., by not engaging the lower cushion 3225 with sufficient force to close or partially close the nostrils). The nasal recess 3228 can prevent unintentional blocking of the patient's nose, which could occur if the lower cushion 3225 was shaped to engage the nose together with the membrane portion 3220 (e.g., by pressing the membrane portion 3220 against the wings of the nose). It should be understood that for some patients with large noses, the lower cushion 3225 may still have a small amount of engagement with a portion of the user's nose, but the user's nose may not be blocked due to the nasal recess 3228. For example, the nasal recess 3228 may be configured to avoid engaging both sides of the patient's nose at the same time. In some examples, the nasal recess 3228 may be configured to provide substantially no medial force on the patient's nose wings during use. In some forms, the nasal recess 3228 is constructed and arranged such that, during use, the lower cushion 3225 does not substantially exert a force on the patient's nose.

[0322] The lower cushion 3225 and frame 3240 can be configured so that in use they are positioned very close to the patient's face in use to allow engagement between the lower cushion 3225 and the patient's cheek and mouth area. The nasal recess 3228 can allow the lower cushion 3225 to be pushed against the patient's cheek and mouth area without excessively forcing the patient's nose to close, which could block the patient's nasal airway.

[0323] The nose recess 3228 in this example (e.g., the portion of the lower cushion 3225 that forms the nose recess 3228) includes a shape corresponding to the lower periphery of the nose (e.g., the lower shape of the front nose portion and the nose wing), such as Fig.11 and 12 The corresponding shape combined with only a small space between the nasal recess 3228 and the patient's nose during use can provide a low-profile patient interface 3000. For example, Fig.11 As shown, the nasal recess 3228 may include an inwardly facing wall 3226. The inwardly facing wall 3226 may face the patient's nose and may also be described as a nasal facing wall. For example, the inwardly facing wall 3226 may be configured to face and at least partially surround the lower periphery of the patient's nose in use. The inwardly facing wall 3226 may be substantially beveled, frustoconical, bowl-shaped, frustosphere-shaped, parabolic, and one or more of other possible shapes. The inwardly facing wall 3226 may be concave, and in some instances concave in two orthogonal planes. For example, when viewed in a vertical section (e.g., a section parallel to the sagittal or coronal plane) and when viewed in a horizontal section (e.g., a section parallel to the Frankfurt horizontal plane), the inwardly facing wall 3226 may include a concave shape. In other instances, the inwardly facing wall 3226 may not be concave in a vertical section, for example, if the inwardly facing wall 3226 is beveled and otherwise appears as a straight line in a vertical section. In some instances, the inward-facing wall 3226 may appear as a straight line in vertical cross-section at one location (e.g., near the anterior nose) but may appear as a curve at another location (e.g., on the side of the patient's nose), or vice versa.

[0324] Fig.18B The nose portion of the lower cushion 3225 is shown parallel to Fig.18A Cross-sectional view in cross section with the coronal plane oriented as shown. Fig.18B As shown, the inwardly facing wall 3226 includes a pair of lateral portions on either lateral side of the nose recess 3228. The lateral portions may face inwardly. They are located on either side of the user's nose during use. Fig.18B It can also be seen that the inwardly facing wall 3226 includes a positive curvature, making it concave. Fig.18BAs shown, the lateral portion of the inward facing wall 3226 can be partially toward the middle and partially toward the upper portion. The inward facing wall 3226 can include the same or similar shape at the front of the inward facing wall 3226, for example, at a position close to the patient's nasal prominence. The front of the inward facing wall 3226 can face rearward and can be positioned in front of and / or below the patient's nasal prominence. The front of the inward facing wall 3226 can face partially toward the rear and partially toward the upper portion. Similar to the lateral portions of the inward facing wall 3226, the front of the inward facing wall 3226 can have a positive curvature and can be concave.

[0325] Fig.19B It shows that Fig.19A A cross-sectional view of the nose of the lower pad 3225 in a horizontal cross-section (e.g., a horizontal plane parallel to the Frankfurt horizontal plane) is shown. Fig.19B As shown, in this example, the inwardly facing wall 3226 is concave in the horizontal plane. The concavity in the horizontal plane results in a nasal recess 3228 surrounding the patient's nose. This shape is Fig.19B Schematically depicted as a semicircle in the figure, and it should be understood that in various examples, the shape of the nasal recess 3228 and its inwardly facing wall 3226 in the horizontal plane can be semicircular or can be a non-circular concave shape, such as a shape closer to a triangle with rounded front angles, sides and no base. In some examples, the nasal recess 3228 can generally have a shape in the horizontal plane that follows the general shape of the patient's nose, such as the lower perimeter of the patient's nose. Fig.19C The shape of the nose recess in another example is schematically illustrated. In this example, the inwardly facing wall 3226 comprises a concave front portion facing the rear and two side portions. The side portions may face primarily inwardly and to a lesser extent rearwardly. Such a shape may more closely follow the shape of a narrow and long nose. Fig.19B The shape shown in can more closely follow the shape of a wide and short nose. In some examples, the lower cushion 3225 (or cushion modules containing the lower cushion 3225) is provided in a range of sizes and / or shapes with the shapes of the nasal recess 3228 and the inward facing wall 3226 varying from the range of cushion module options so that each patient can select a cushion module with the best fitting lower cushion 3225 for their nose and mouth.

[0326] In some examples, the nasal recess 3228 substantially surrounds all lateral and forward facing portions of the lower periphery of the patient's nose in use. The inwardly facing wall 3226 may extend from around the patient's nose at or near one cheek of the patient to at or near the other cheek of the patient.

[0327] Reference Fig.11 and 12, the lower cushion 3225 in this particular embodiment further includes a pair of rear support portions 3227, each rear support portion 3227 being located on a respective side of the nasal recess 3228 and configured to engage the patient's face in the middle and near the nasolabial grooves of the patient's face. For example, these rear support portions 3227 can engage the patient's face at a location below the ala of the nose on either side above the patient's lips, or can engage the patient's face at a location vertically aligned with the patient's ala of the nose between the ala of the nose and the nasolabial grooves. In some instances, the rear support portions 3227 can engage the patient's face in an area extending vertically from beside the ala of the nose to beside the top of the patient's lips. The rear support portions 3227 can engage the face to support the patient interface 3000 in an appropriate position, and can also advantageously cause the membrane portion 3220 to form a good seal near the lower corners of the patient's nose, which may be more difficult to seal against a wide range of patients compared to other locations such as the cheeks. For example, as Fig.11 As shown, the inward-facing wall 3226 can extend from a first one of the rear support portions 3227 surrounding the patient's nose to another one of the rear support portions 3227.

[0328] exist Fig.11 In the example shown, the rear support portions 3227 also each include an area of ​​the inwardly facing wall 3226, although this may be a relatively small area compared to the overall size of the inwardly facing wall 3226. In this example, each of the rear support portions 3227 is shaped to protrude at least partially in the middle into a depression formed on the patient's face on either side of the ala of the nose, such as between the ala of the nose and an adjacent portion of the patient's face. For example, the rearwardly facing surface or portion of each rear support portion 3227 may engage the patient's face in the area between the nasolabial groove and the ala of the nose. At the same time, a portion of the inwardly facing surface 3226 that forms a portion of each rear support portion 3227 or is positioned adjacent to each rear support portion 3227 may engage a corresponding one of the patient's ala of the nose. The rear support portion 3227 may "dig into" the depression on either side of the patient's nose to help achieve a good seal in these areas. The rear support portion 3227 may only engage the ala of the nose at the very back. The rear support portion 3227 may contact the ala of the nose to promote sealing of the concave surface on either side of the lower periphery of the patient's nose. The lower cushion 3225 is still configured to avoid applying medial forces on the patient's nose that tend to obstruct the nasal airway.

[0329] exist Figure 7-13 In the example shown, the membrane portion 3220 is connected to the lower cushion 3225 around the periphery of the nasal recess 3228. In particular, as shown in FIG. Fig.11 and 12As shown, the lower pad 3225 includes an upwardly facing surface 3229, which is positioned adjacent to the nasal recess 3228 and is arranged around the periphery of the nasal recess 3228, and the membrane portion 3220 is connected to the upwardly facing surface 3229 of the lower pad 3225. The membrane portion 3220 can be glued, bonded or otherwise connected to the upwardly facing surface 3229. In some examples, the upwardly facing surface 3229 can be flat. In other examples, the upwardly facing surface 3229 can have a small curvature in cross section, but not to the extent that the membrane portion 3220 cannot be firmly connected to the upwardly facing surface 3229. In other examples, the membrane portion 3220 is connected to a connecting surface of the nasal portion, which may or may not be facing upward. The portion defining the nasal recess 3228 can have a consistent wall cross-section around the nasal recess 3228 to avoid weak points in some examples. That is, in some examples, the nose portion of the lower cushion 3225 can include a middle recess 3229a in the upwardly facing surface 3229. The middle recess 3229a can be configured to provide clearance for the nasal prominence and / or reduce pressure on the nasal prominence in the event that there is unintentional engagement between the lower cushion 3225 and the nasal prominence. Although the nasal recess 3228 and the middle recess 3229a are intended to provide clearance for the nose and its forehead, respectively, it should be understood that for some patients, in one or more positions, there may be some engagement between the lower cushion 3225 and the nose. However, the nasal recess 3228 and the middle recess 3229a are still understood to be configured (e.g., constructed, shaped, arranged and / or positioned) to provide clearance because they are generally shaped to avoid contact with the nose and the nasal prominence, respectively, and result in less contact than would otherwise occur.

[0330] In an example, the lower pad 3225 formed of a foam material is made of polyurethane, thermoplastic or thermosetting polyurethane, or of a thermoplastic elastomer (e.g., a soft TPE having similar behavior to foam). Foams having the following properties may be suitable:

[0331] • Force deflection: 95 + / - 20N @40% (Test specification: AS 2282.8 Method A)

[0332] • Density: 54.5+ / -2.5kg / m3 (test specification: AS 2282.3)

[0333] • Air permeability: <1.5 l / min @ 20cm H2O (R630-602 Permeability Test (Ring) Procedure).

[0334] In some examples, foams having a lower density than those described above may be used to form the lower cushion 3225. In some examples, the lower cushion 3225 may be formed of a low density foam, but may have a sufficiently thick base or body to adequately support the fabric membrane 3220 and itself, particularly in the nasal region.

[0335] In other examples, any of polyethylene foam, silicone foam, or EVA foam may be used, among other examples.

[0336] In some examples, foam underpad 3225 may be formed by molding, such as injection molding.

[0337] In an example, the foam can be substantially water-impermeable so that the mask can be fully dried when washed earlier in the day before use at night.

[0338] In an example, the lower cushion material is soft enough to not cause substantial discomfort when engaging the face, but hard enough to retain the frame and hold the frame in a sealing manner when the patient interface is worn.

[0339] In an example, the foam from which the lower pad 3225 is made is substantially air-impermeable, for example, the foam can be a skin foam.

[0340] In use, the lower pad 3225 supports the membrane portion 3220.

[0341] 4.3.3.2 Membrane part

[0342] As described above, the patient interface 3000 may include a membrane portion 3220 that engages the patient's face. In various examples, the membrane portion 3220 may be at least partially formed of a fabric material, of an elastomer such as silicone or TPE, or of another suitable material. Fig.10 and 13 In one form, the seal-forming structure includes a fabric membrane portion 3220 that acts as a pressure-assisted sealing mechanism. In use, the fabric membrane portion 3220 can readily respond to the system positive pressure acting on its inner side inside the inflatable chamber 3200 to urge it into tight sealing engagement with the surface. The pressure-assisted mechanism can act together with the elastic tension in the positioning and stabilizing structure 3300. In other examples, the membrane portion 3220 can be formed of silicone, such as a silicone membrane having a thickness of 0.2-0.4 mm or 0.25-0.3 mm.

[0343] like Fig.16As shown, in some examples, the membrane portion 3220 is connected to the patient-facing side of the lower cushion 3225 at its outer periphery so that the membrane is substantially taut when not in use. For example, the membrane portion 3220 can be bonded to the lower cushion 3225. In an example, the only connection between the fabric membrane portion 3220 and the lower cushion 3225 is at the outer periphery of the fabric membrane portion 3220. When subjected to the processing pressure within the inflation chamber 3200, the fabric membrane portion 3220 can be "inflated" under pressure. This may cause the fabric membrane portion 3220 to closely conform to the shape of the patient's face. In one form, the membrane portion 3220 may be configured to form a seal at least to the nasal protrusion area and the nasal wings of the patient's nose, and may also form a seal to the patient's upper lip. The seal-forming structure 3100, such as a portion or another portion of the membrane portion 3220, may be further configured to form a seal around the patient's mouth.

[0344] In some examples, the membrane portion 3220 is formed from a single fabric sheet. The membrane portion 3220 may include a first hole 3150 through which air can flow from the plenum 3200 to the patient's two nostrils and a second hole 3160 through which air can flow from the plenum 3200 to the patient's mouth. The membrane portion 3220 may extend between the first and second holes 3150, 3160. For example, Fig.17 As shown, the first hole 3150 can be a generally triangular shape with rounded sides and corners. The back side of the first hole 3150 can be wider than the front side to correspond to the general shape of the lower periphery of the patient's nose.

[0345] In other examples (not shown), there may be a single hole for the patient's mouth and nostrils in the membrane portion 3220. In examples, the membrane portion 3220 may effectively have only a single hole, but the opposing lateral sides of the membrane portion 3220 at the edge of the hole may be connected by a bridge portion, such as a fabric bridge portion, which may be positioned directly across the patient's upper lip.

[0346] The membrane portion 3220 may be connected to the lower cushion 3225 around the periphery of the above-mentioned nasal recess 3228. The membrane portion 3220 may be connected to the lower cushion 3225 across the nasal recess 3228 so that the membrane portion 3220 is pulled tight when the patient interface 3000 is not in use. This pulled tight configuration may mean that when the membrane portion 3220 is in contact with the patient's nose and the patient's nose is pressed into the nasal recess 3228, the first hole 3150 in the membrane portion 3220 will be directly below the nose and will be tightened around the patient's nostril in preparation for a pressurized seal in use. The application of pressurized air in the plenum 3200 will then push the membrane portion 3220 and apply additional sealing force around the first hole 3150.

[0347] Specific as Fig.13As shown, the patient's nose is pressed into the membrane portion 3220 above the nasal recess 3228, while the membrane portion 3220 on the underside of the nose "cups" the underside of the nose, forming a seal against the edge of the nose. In use, the lower periphery of the patient's nose can be located within the nasal recess 3228, but spaced apart from the lower cushion 3225 around the periphery of the nasal recess 3228. The membrane portion 3220 can bridge the gap between the patient's nose and the lower cushion 3225 around the periphery of the nasal recess 3228. In use, the inwardly facing wall 3226 can be spaced apart from the patient's nose, or, if the inwardly facing wall 3226 inadvertently engages the patient's nose in some patients, it can do so with minimal or substantially no force.

[0348] In some examples, the membrane portion 3220 can be configured to be stretched by the patient's nose in the vicinity of the first aperture 3150 during use. The membrane portion 3220 can be configured to stretch around the base of the nostril when the nose is placed on the membrane portion 3220 and pressed down into the nasal recess 3228. The stretching of the first aperture 3150 can cause the membrane portion 3220 to lie flat and tightly against the underside of the patient's nose. The stretching of the first aperture 3150 can also relieve tension in the membrane portion 3220, which can prevent or provide only a low probability that the portion of the lower cushion 3225 defining the sides of the nasal recess 3228 is pulled into the nasal recess 3228, which can cause nasal obstruction.

[0349] The fabric membrane portion 3220 may be coated with an airtight coating, such as a silicone coating. In one example, the silicone coating has a thickness in the range of 0.02 mm-0.05 mm (or in the range of 0.03 mm-0.05 mm), and the fabric membrane portion 3220 including the coating is substantially 0.3 mm thick. The coating may be on the non-patient contacting side of the fabric membrane portion 3220.

[0350] The fabric membrane portion 3220 may include a knitted fabric. The membrane portion 3220 may be highly flexible so as to easily conform to the shape of the patient's face. In an example, the textile may include polyamide (e.g., nylon), polyester, and / or elastic fibers (e.g., spandex).

[0351] In one example, a fabric having the following properties may be used:

[0352] •Single jersey;

[0353] •Content: Polyamide 80%, elastane 20%;

[0354] • Density: 136 rows per inch, 75 lines per inch;

[0355] • Weight: 105 g / m2; and

[0356] •Elongation at 1.5 kg: 80-108% in length, 93-126% in width.

[0357] In an example, the frame 3240 and / or the lower pad 3225 are shaped so that the patient-facing side of the fabric membrane portion 3220 lies on a continuous convex curve when viewed in a cross-section through a sagittal plane (e.g., a mid-sagittal plane). In some examples, due to the high flexibility in the frame 3240, only the lower pad 3225 maintains the shape of the membrane portion 3220.

[0358] For example, the fabric membrane portion 3220 may not have secondary geometric features that may create creases. This allows the membrane to be maintained in a non-crease configuration when the patient interface 3000 is not in use. When the patient interface 3000 is applied to the face, the membrane portion 3220 bends and forms to the face, particularly around the perimeter of the nose and oral openings, as these may be the first points of engagement.

[0359] The highly compliant fabric membrane portion 3220 activated with pressure can advantageously allow for a strong seal. When applied to the compliant fabric membrane portion 3220, the processing pressure can allow it to easily form to varying facial shapes. The compliant nature of the fabric membrane and / or the larger area of ​​contact between the membrane and the patient's face can help reduce areas of discomfort between the seal-forming structure 3100 and the patient's face, as may exist in less compliant seal-forming structures of the prior art. In an example, the textile can be a fine knit. The surface of the textile can be relatively smooth to allow the patient to more easily position the interface when wearing it and to ensure that the fabric remains draped over the patient's skin.

[0360] 4.3.4 Positioning and stabilizing the structure

[0361] The seal-forming structure 3100 of the patient interface 3000 of the present technology may be maintained in a sealed state during use by the positioning and stabilizing structure 3300 .

[0362] In one form, the positioning and stabilising structure 3300 provides a retaining force that is at least sufficient to overcome the positive pressure in the plenum 3200 to lift off the face.

[0363] In one form, the positioning and stabilising structure 3300 provides a retaining force to overcome the effects of gravity on the patient interface 3000 .

[0364] In one form, the positioning and stabilising structure 3300 provides a retaining force as a safety margin to overcome the potential effects of damaging forces on the patient interface 3000, such as from tube drag or accidental interference with the patient interface.

[0365] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is constructed in a manner consistent with being worn by a patient while sleeping. In one example, the positioning and stabilizing structure 3300 has a small side or cross-sectional thickness to reduce the sensed or actual volume of the instrument. In one example, the positioning and stabilizing structure 3300 includes at least one strap that is rectangular in cross-section. In one example, the positioning and stabilizing structure 3300 includes at least one flat strap.

[0366] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured so as not to be too large and bulky to prevent a patient from lying in a supine sleeping position with the back area of ​​the patient's head on a pillow.

[0367] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured to not be so large and bulky as to prevent a patient from lying in a side sleeping position with the side area of ​​the patient's head on a pillow.

[0368] In one form of the present technology, the positioning and stabilising structure 3300 is provided with a decoupling portion between the front of the positioning and stabilising structure 3300 and the back of the positioning and stabilising structure 3300. The decoupling portion does not resist compression and may be, for example, a flexible strap or floppy strap. The decoupling portion is constructed and arranged such that when the patient lies their head on the pillow, the presence of the decoupling portion prevents forces acting on the back from being transmitted along the positioning and stabilising structure 3300 and disrupting the seal.

[0369] In one form of the present technology, the positioning and stabilizing structure 3300 comprises a strap constructed from a laminate of a fabric patient contacting layer, a foam inner layer, and a fabric outer layer. In one form, the foam is porous to allow moisture (e.g., sweat) to pass through the strap. In one form, the fabric outer layer comprises a loop material for engaging with a hook material portion.

[0370] In some forms of the present technology, the positioning and stabilizing structure 3300 includes a strap that is extendable, such as elastically extendable. For example, the strap can be configured to be in a tensioned state when in use and to direct a force to cause the seal-forming structure to seal with a portion of the patient's face. In one example, the strap can be configured as a tie.

[0371] In one form of the present technology, the positioning and stabilizing structure includes a first strap, which is constructed and arranged so that in use, at least a portion of the lower edge of the first strap passes through the upper ear base of the patient's head and covers a portion of the parietal bone without covering the occipital bone.

[0372] In one form of the present technology applicable to a nasal-only mask or to a full-face mask, the positioning and stabilizing structure includes a second strap, which is constructed and arranged so that in use, at least a portion of the upper edge of the second strap passes under the inferior ear base of the patient's head and covers the occipital bone of the patient's head or is located below the occipital bone of the patient's head.

[0373] In one form of the present technology suitable for use with a nasal-only mask or with a full-face mask, the positioning and stabilizing structure includes a third strap constructed and arranged to interconnect the first strap and the second strap to reduce the tendency of the first strap and the second strap to separate from each other.

[0374] In some forms of the present technology, the positioning and stabilizing structure 3300 comprises a strap that is flexible and, for example, non-rigid. An advantage of this aspect is that the strap makes it more comfortable for the patient to lie on while sleeping.

[0375] In some forms of the present technology, the positioning and stabilizing structure 3300 includes a strap configured to be breathable to allow moisture vapor to be transmitted through the strap.

[0376] In some forms of the present technology, a system is provided that includes more than one positioning and stabilizing structure 3300, each positioning and stabilizing structure configured to provide retention forces to correspond to a different range of sizes and / or shapes. For example, the system may include one form of positioning and stabilizing structure 3300 that is suitable for large sized heads but not for small sized heads, while another form of positioning and stabilizing structure is suitable for small sized heads but not for large sized heads.

[0377] 4.3.5 Connectors for positioning and stabilizing structures

[0378] like Figure 7 and 8 As shown, in an example, connectors for connecting the positioning and stabilizing structure 3300 to the patient interface 3000 are provided to the frame 3240. In an example, the frame 3240 is provided with a pair of upper headband connector portions 3310 and a pair of lower headband connector portions 3320.

[0379] Each upper headband connector portion 3310 may include a curved arm. Figure 7 and Figure 8 In the example shown, the upper headband connector portion 3310 is in the form of rigid arms, each arm being provided with a strap engaging means (e.g. a loop or groove) for engaging a headband strap at or near its end. The rigid arms may extend laterally from the frame 3240 and then bend to extend rearwardly in use. The arms may also bend in an upward direction in use.

[0380] exist Figure 7 and8 In the example shown, the lower headband connector portion 3320 includes a magnetic connector that can engage a complementary connector connected to the lower headband strap.

[0381] like Fig.15 As shown (only one side is visible), the upper headband connector portion 3310 is connected to the upper headband strap 3311 and the lower headband strap connector portion 3320 is connected to the lower headband strap 3321.

[0382] It will be appreciated that any suitable positioning and stabilising structure 3300 may be provided to the patient interface 3000 and any suitable corresponding headgear connectors may be provided to the frame 3240 or cushion module in accordance with examples of the present technology.

[0383] 4.3.6 Ventilation

[0384] In one form, the patient interface 3000 includes a vent 3400 constructed and arranged to allow flushing of exhaled gases, such as carbon dioxide.

[0385] In some forms, vent 3400 is configured to allow continuous ventilation flow from the interior of plenum chamber 3200 to the surrounding environment while the pressure within the plenum chamber is positive relative to the surrounding environment. Vent 3400 is configured so that the vent flow has a sufficient amount to reduce the patient's exposure to exhaled CO. 2 The amplitude of rebreathing while maintaining the therapeutic pressure in the inflation chamber during use.

[0386] One form of a vent 3400 according to the present technology includes a plurality of holes, for example, about 20 to about 80 holes, or about 40 to about 60 holes, or about 45 to about 55 holes.

[0387] The vent 3400 may be located in the plenum chamber 3200. Alternatively, the vent 3400 is located in a decoupling structure such as a rotary joint. Figure 7-13 15-17, the vent 3400 of the patient interface 3000 is located in the connector 3620. In other examples, it can be located in the frame 3240 or even in the lower cushion 3225.

[0388] 4.3.7 Decoupling Structure

[0389] In one form, the patient interface 3000 includes at least one decoupling structure, such as a swivel or a ball and socket.

[0390] As mentioned above, in Figure 7-13In the examples shown in Figures 15-17, the frame 3240 is connected to the short tube 3610 by a connector 3620. In this example, the connector 3620 is in the form of an elbow. In other examples, it can be a straight connector. In this example, the connector 3620 provides a ball joint connection with the frame 3240 to provide multiple rotation axes, and in other examples, the connector 3620 can be connected to the frame so as to rotate only around a single axis (e.g., an axis coaxial with the hole in the frame 3240). In this example, the connector 3620 may include an additional part that rotates independently of the part that rotates within the frame 3240 to provide an additional rotation axis that can be used for the connection between the short tube 3610 and the frame 3240. The connector 3620 can be detachably connected to the frame 3240. The connector 3620 forms a decoupling structure by being able to rotate around one or more axes relative to the frame 3240.

[0391] Figure 7-13 The short tube 3610 in the examples shown in Figures 15-17 also forms a decoupling structure because the short tube 3610 decouples the movement of the air circuit 4170 to which it is connected from the frame 3420, at least partially alleviating the effects of tube drag during use. In addition, in some examples, the connection port 3600 may include a rotational connection to the air circuit, providing additional or alternative decoupling of the air circuit 4170 from the frame 3420.

[0392] 4.3.8 Connection Port

[0393] Connection port 3600 allows connection to air circuit 4170. Figure 7-13 15-17, the connection port 3600 is located at the distal end of the short tube 3610. In another example, the connection port 3600 can be connected to the frame 3240 without the short tube 3610. In such an example, the connection port 3600 can be provided by an elbow that is fluidly connected to the frame 3240 and is configured to be fluidly connected to the air circuit 4170.

[0394] 4.3.9 Forehead support

[0395] In one form, the patient interface 3000 includes a forehead support 3700 .

[0396] 4.3.10 Anti-asphyxia valve

[0397] In one form, patient interface 3000 includes an anti-asphyxia valve.

[0398] 4.3.11 Ports

[0399] In one form of the present technology, the patient interface 3000 includes one or more ports that allow access to the volume within the plenum chamber 3200. In one form, this allows the clinician to supply supplemental oxygen. In one form, this allows direct measurement of properties of the gas within the plenum chamber 3200, such as pressure.

[0400] 4.4RPT device

[0401] The RPT device 4000 according to one aspect of the present technology includes mechanical, pneumatic and / or electrical components and is configured to execute one or more algorithms, such as all or part of the methods described herein. The RPT device 4000 can be configured to generate an air flow for delivery to the airway of a patient, such as for treating one or more respiratory conditions described elsewhere in this document.

[0402] In one form, the RPT device 4000 is constructed and arranged to deliver air flow in the range of -20 L / min to +150 L / min while maintaining at least 6 cmH 2 O, or at least 10cmH 2 O, or at least 20 cmH 2 Positive pressure of O.

[0403] The RPT device can have an outer housing 4010 that is constructed in two parts: an upper portion 4012 and a lower portion 4014. In addition, the outer housing 4010 can include one or more panels 4015. The RPT device 4000 includes a chassis 4016 that supports one or more internal components of the RPT device 4000. The RPT device 4000 can include a handle 4018.

[0404] The pneumatic path of the RPT device 4000 may include one or more air path items in the air path, such as one or more air filters 4110, such as an inlet air filter 4112 and / or an outlet air filter 4114; an inlet muffler 4122; a pressure generator 4140 capable of supplying air at a positive pressure (e.g., a blower 4142 including a motor 4144); one or more mufflers 4120, such as an outlet muffler 4124; and one or more converters 4270, such as a pressure sensor and a flow sensor.

[0405] One or more of the air path items may be disposed within a removable separate structure, which will be referred to as a pneumatic block 4020. The pneumatic block 4020 may be disposed within the outer housing 4010. In one form, the pneumatic block 4020 is supported by, or forms part of, the chassis 4016. An anti-splashback valve 4160 may be disposed between the pneumatic block 4020 and the humidifier 5000.

[0406] The RPT device 4000 may have a power source 4210, one or more input devices 4220, a central controller 4230, a treatment device controller 4240, a pressure generator 4140, one or more protection circuits 4250, a memory 4260, a converter 4270, a data communication interface 4280, and one or more output devices 4290. The electrical components may be mounted on a single printed circuit board assembly (PCBA) 4202. In an alternative form, the RPT device 4000 may include more than one PCBA 4202.

[0407] 4.4.1RPT device algorithm

[0408] As described above, in some forms of the present technology, the central controller 4230 may be configured to implement one or more algorithms represented as computer programs stored in a non-transitory computer-readable storage medium such as a memory. Algorithms are generally grouped into groups called modules.

[0409] In other forms of the present technology, some or all of the algorithm may be implemented by a controller of an external device such as a local external device or a remote external device. In this form, data representing input signals and / or intermediate algorithm outputs required for the portion of the algorithm to be executed at the external device may be transmitted to the external device via a local external communication network or a remote external communication network. In this form, the portion of the algorithm to be executed at the external device may be represented as a computer program stored in a non-transitory computer-readable storage medium accessible to the controller of the external device. Such a program configures the controller of the external device to execute portions of the algorithm.

[0410] In such a form, therapy parameters generated by the external device via the therapy engine module (if so forming part of the algorithm executed by the external device) may be transmitted to the central controller to be passed to the therapy control module.

[0411] 4.5 Air circuit

[0412] The air circuit 4170 according to one aspect of the present technology is a conduit or tube that, when in use, is configured and arranged to allow air flow to travel between two components, such as the RPT device 4000 and the patient interface 3000 or 3800 .

[0413] Specifically, the air circuit 4170 can be fluidly connected to the outlet of the pneumatic block 4020 and the patient interface. The air circuit can be referred to as an air delivery tube. In some cases, there can be separate branches for the inspiratory and expiratory circuits. In other cases, a single branch is used.

[0414] In some forms, the air circuit 4170 may include one or more heating elements configured to heat the air in the air circuit, for example to maintain or increase the temperature of the air. The heating element may be in the form of a heating wire loop and may include one or more transducers, such as a temperature sensor. In one form, the heating wire loop may be helically wound around the axis of the air circuit 4170. The heating element may be in communication with a controller such as a central controller 4230. An example of an air circuit 4170 including a heating wire loop is described in U.S. Patent 8,733,349, which is incorporated herein by reference in its entirety.

[0415] 4.5.1 Supplementary gas delivery

[0416] In one form of the present technology, supplemental gas, namely supplemental oxygen 4180 , is delivered to one or more points in the pneumatic pathway, such as upstream of the pneumatic block 4020 , the air circuit 4170 , and / or the patient interface 3000 or 3800 .

[0417] 4.6 Humidifier

[0418] 4.6.1 Humidifier Overview

[0419] In one form of the present technology, a humidifier 5000 (e.g., Figure 5A ) to change the absolute humidity of the air or gas for delivery to the patient relative to the ambient air. Typically, the humidifier 5000 is used to increase the absolute humidity of the air flow and increase the temperature of the air flow (relative to the ambient air) before delivery to the patient's airway.

[0420] The humidifier 5000 may include a humidifier reservoir 5110, a humidifier inlet 5002 for receiving an air flow, and a humidifier outlet 5004 for delivering a humidified air flow. Figure 5A and Figure 5B As shown, the inlet and outlet of the humidifier reservoir 5110 can be a humidifier inlet 5002 and a humidifier outlet 5004, respectively. The humidifier 5000 can also include a humidifier base 5006, which can be adapted to receive the humidifier reservoir 5110 and include a heating element 5240. The reservoir 5110 includes a conductive portion 5120 configured to allow efficient transfer of heat from the heating element 5240 to the liquid content in the reservoir 5110. The reservoir 5110 can include a water level indicator 5150.

[0421] In some arrangements, the humidifier reservoir base 5130 may include a locking structure, such as a locking rod 5135 configured to retain the reservoir 5110 in the humidifier reservoir base 5130.

[0422] 4.7 Respiratory waveform

[0423] Fig. 6A The following figure shows a typical breathing waveform of a model of a person during sleep. The horizontal axis is time and the vertical axis is respiratory flow. While the parameter values ​​can vary, a typical breath can have the following approximate values: tidal volume Vt 0.5L, inspiratory time Ti 1.6s, peak inspiratory flow Qpeak 0.4 L / s, expiratory time Te 2.4s, peak expiratory flow Qpeak-0.5L / s. The total duration of the breath Ttot is about 4s. People usually breathe at a rate of about 15 breaths per minute (BPM) and a ventilation rate of Vent of about 7.5L / min. The typical duty cycle, the ratio of Ti to Ttot is about 40%.

[0424] 4.8 Respiratory therapy mode

[0425] Various respiratory therapy modes may be achieved through the disclosed respiratory therapy system, including CPAP therapy, bi-level therapy, and / or high flow therapy.

[0426] 4.9 Glossary

[0427] For purposes of this technical disclosure, one or more of the following definitions may apply in certain forms of the technology. In other forms of the technology, alternative definitions may apply.

[0428] 4.9.1 General

[0429] Air: In some forms of the present technology, air may be considered to mean atmospheric air, and in other forms of the present technology, air may be considered to mean some other combination of breathable gases, such as atmospheric air enriched with oxygen.

[0430] Environment: In certain forms of the present technology, the term environment can have the following meanings: (i) external to the treatment system or patient, and (ii) directly surrounding the treatment system or patient.

[0431] For example, relative to the environment of the humidifier humidity This may be the humidity of the air directly surrounding the humidifier, such as the humidity inside the room that the patient is sleeping in. This ambient humidity may be different from the humidity outside the room that the patient is sleeping in.

[0432] In another example, ambient pressure can be the pressure immediately surrounding or external to the body.

[0433] In some forms, ambient (e.g., acoustic) noise may be considered to be the background noise level in the room the patient is in, in addition to noise generated, for example, by the RPT device or from a mask or patient interface. Ambient noise may be generated by sound sources outside the room.

[0434] Automatic Positive Airway Pressure (APAP) Therapy: CPAP therapy in which the therapy pressure is automatically adjustable between a minimum and a maximum limit, e.g., with each breath, depending on whether there is an indication of an SBD event.

[0435] Continuous Positive Airway Pressure (CPAP) therapy: A breathing pressure therapy in which the therapy pressure can be approximately constant throughout the patient's breathing cycle. In some forms, the pressure at the airway entrance will be slightly higher during exhalation and slightly lower during inspiration. In some forms, the pressure will vary between different breathing cycles of the patient, for example, increasing in response to detecting an indication of partial upper airway obstruction, and decreasing in the absence of an indication of partial upper airway obstruction.

[0436] Flow rate: The volume (or mass) of air delivered per unit time. Flow rate may refer to an instantaneous quantity. In some cases, reference to flow rate will be to a scalar quantity, i.e. a quantity having only magnitude. In other cases, reference to flow rate will be to a vector quantity, i.e. a quantity having both magnitude and direction. Flow rate may be given by the symbol Q. 'Flow rate' is sometimes simply abbreviated to 'flow' or 'air flow'.

[0437] In the example of a patient breathing, the flow may be nominally positive for the inspiratory portion of the patient's breathing cycle, and therefore negative for the expiratory portion of the patient's breathing cycle. The device flow Qd is the flow of air leaving the RPT device. The total flow Qt is the flow of air and any supplemental gas that reaches the patient interface via the air circuit. The ventilation flow Qv is the flow of air leaving the vent to allow flushing of exhaled gases. The leakage flow Ql is the leakage flow from the patient interface system or elsewhere. The respiratory flow Qr is the flow of air received into the patient's respiratory system.

[0438] Flow Therapy: Respiratory therapy that involves delivering a flow of air to the airway entrance at a controlled flow rate, called the therapeutic flow rate, which is usually positive throughout the patient's respiratory cycle.

[0439] Humidifier: The term humidifier shall be deemed to refer to a humidifying device constructed and arranged or configured with a physical structure capable of providing a therapeutically beneficial amount of water (H2O) to an air flow. 2 O) steam to improve the patient's medical respiratory condition.

[0440] Leakage: The word leakage is to be considered as undesired air flow. In one example, leakage may occur due to an incomplete seal between the mask and the patient's face. In another example, leakage may occur in the swivel elbow to the surrounding environment.

[0441] Noise, conducted (acoustic): Conducted noise in this document refers to the noise brought to the patient through the pneumatic path (such as the air circuit and patient interface and the air therein). In one form, conducted noise can be quantified by measuring the sound pressure level at the end of the air circuit.

[0442] Noise, radiated (acoustic): Radiated noise in this document is the noise that is brought to the patient through the surrounding air. In one form, radiated noise can be quantified by measuring the sound power / pressure level of the object in question according to ISO 3744.

[0443] Noise, ventilatory (acoustic): Ventilatory noise in this document refers to the noise generated by the flow of air through any vent, such as the vent of a patient interface.

[0444] Patient: A person, whether or not they have a respiratory condition.

[0445] Pressure: Force per unit area. Pressure can be expressed in a range of units, including cmH 2 O, gf / cm 2 , hectopascal. 1 cmH 2 0 is equal to 1 gf / cm 2 And about 0.98 hPa (1 hPa = 100 Pa = 100 N / m 2 = 1 mbar ~ 0.001 atmosphere (atm)). In this specification, unless otherwise specified, pressure is expressed in cmH 2 The units are given in O.

[0446] The pressure in the patient interface is given the symbol Pm, while the treatment pressure is given the symbol Pt, which represents the target value to be achieved by the interface pressure Pm at the current moment.

[0447] Respiratory Pressure Therapy (RPT): The application of a supply of air to the airway entrance at a therapeutic pressure that is typically positive relative to atmosphere.

[0448] Ventilator: A mechanical device that provides pressure support to a patient to perform some or all of the work of breathing.

[0449] 4.9.1.1 Materials

[0450] Silicone or Silicone Elastomer: A synthetic rubber. In this specification, references to silicone refer to liquid silicone rubber (LSR) or compression molded silicone rubber (CMSR). One form of commercially available LSR is SILASTIC (included in the range of products sold under this trademark), which is manufactured by Dow Corning. Another manufacturer of LSR is Wacker. Unless otherwise specified to the contrary, exemplary forms of LSR have a Shore A (or Type A) indentation hardness in the range of about 35 to about 45 as measured using ASTM D2240.

[0451] Polycarbonate: A transparent thermoplastic polymer of bisphenol A carbonate.

[0452] 4.9.1.2 Mechanical properties

[0453] Resilience: The ability of a material to absorb energy when elastically deformed and release that energy when unloaded.

[0454] Elastic: Will release substantially all of its energy when unloaded. Includes, for example, certain silicones and thermoplastic elastomers.

[0455] Hardness: The ability of a material to resist deformation (e.g. as described by Young's modulus or the indentation hardness scale measured on a standardized sample size).

[0456] • “Soft” materials may include silicone or thermoplastic elastomers (TPEs) and may deform easily, for example, under finger pressure.

[0457] • “Hard” materials may include polycarbonate, polypropylene, steel or aluminum, and may not deform easily, for example, under finger pressure.

[0458] Stiffness (or rigidity) of a structure or component: The ability of a structure or component to resist deformation in response to an applied load. The load can be a force or a moment, such as compression, tension, bending, or torsion. A structure or component can offer different resistance in different directions. The inverse of stiffness is compliance.

[0459] Flexible structure or component: A structure or component that will change shape (eg, bend) when made to support its own weight for a relatively short period of time, such as within 1 second.

[0460] Rigid structure or component: A structure or component that does not substantially change shape when subjected to loads normally encountered in use. Examples of such use may be, for example, a rigid structure or component that does not substantially change shape when subjected to loads normally encountered in use. 2 O pressure, set and maintain the patient interface in a sealed relationship with the entrance of the patient's airway.

[0461] As an example, an I-beam may include a different bending stiffness (resistance to bending loads) in a first direction than in a second orthogonal direction. In another example, a structure or component may be flexible in a first direction and rigid in a second direction.

[0462] 4.9.2 Respiratory cycle

[0463] Apnea: According to some definitions, an apnea is considered to occur when flow drops below a predetermined threshold for a sustained period of time (e.g., 10 seconds). Obstructive apnea is considered to occur when some obstruction of the airway does not allow air to flow despite the patient's efforts. Central apnea is considered to occur when apnea is detected due to a decrease or absence of respiratory effort despite a patent airway. Mixed apnea is considered to occur when a decrease or absence of respiratory effort occurs simultaneously with an obstructed airway.

[0464] Respiratory Rate: The rate at which a patient breathes spontaneously, usually measured in breaths per minute.

[0465] Duty cycle: the ratio of inspiratory time Ti to total breathing time Ttot.

[0466] Effort (of breathing): The work done by a spontaneous breather in an attempt to breathe.

[0467] Expiratory portion of the respiratory cycle: the period from the start of expiratory flow to the start of inspiratory flow.

[0468] Flow Limitation: Flow limitation is to be considered a state in a patient's breathing where an increase in the patient's effort does not result in a corresponding increase in flow. Where flow limitation occurs during the inspiratory portion of the breathing cycle, it may be described as inspiratory flow limitation. Where flow limitation occurs during the expiratory portion of the breathing cycle, it may be described as expiratory flow limitation.

[0469] Types of flow-limited inspiratory waveforms:

[0470] (i) Flattened: Having a rise followed by a relatively flat section and then a fall.

[0471] (ii) M-shape: has two local peaks, one at the leading edge and one at the trailing edge, with a relatively flat portion between the two peaks.

[0472] (iii) Chair shape: has a single local peak at the leading edge followed by a relatively flat section.

[0473] (iv) Reverse chair shape: has a relatively flat section followed by a single local peak located at the trailing edge.

[0474] Hypopnea: According to some definitions, hypopnea is considered a decrease in flow rather than a cessation of flow. In one form, hypopnea is considered to occur when flow decreases below a threshold for a sustained period of time. Central hypopnea is considered to occur when hypopnea is detected due to a decrease in respiratory effort. In one form in adults, any of the following may be considered hypopnea:

[0475] (i) The patient has a 30% decrease in respiration lasting at least 10 seconds with an associated 4% desaturation;

[0476] (ii) The patient has a decrease in breathing (but less than 50%) lasting at least 10 seconds, with an associated desaturation or arousal of at least 3%.

[0477] Hyperpnea: Increased air flow to above normal levels.

[0478] Inspiratory portion of the respiratory cycle: The period from the start of inspiratory flow to the start of expiratory flow is considered the inspiratory portion of the respiratory cycle.

[0479] Patency (airway): The degree to which the airway is open or the degree to which the airway is open. An open airway is open. Airway patency can be quantified, for example with a value of (1) for open, and a value of zero (0) for closed (obstructed).

[0480] Positive End-Expiratory Pressure (PEEP): The pressure above atmospheric pressure that exists in the lungs at the end of exhalation.

[0481] Peak Flow (Q-peak): The maximum value of flow during the inspiratory portion of the respiratory flow waveform.

[0482] Respiratory flow, patient air flow, respiratory air flow (Qr): These synonymous terms may be understood to refer to the RPT device’s estimate of respiratory flow, as opposed to “true respiratory flow” or “real respiratory flow,” which is the actual respiratory flow experienced by the patient, usually expressed in liters per minute.

[0483] Tidal volume (Vt): The volume of air inhaled or exhaled during normal breathing when no additional effort is exerted. In principle, the inspiratory volume Vi (the volume of air inhaled) is equal to the expiratory volume Ve (the volume of air exhaled), so a single tidal volume Vt can be defined to be equal to either volume. In practice, the tidal volume Vt is estimated as some combination of the inspiratory volume Vi and the expiratory volume Ve, such as an average.

[0484] (Inspiratory) Time (Ti): Duration of the inspiratory portion of the respiratory flow waveform.

[0485] (Expiratory) Time (Te): Duration of the expiratory portion of the respiratory flow waveform.

[0486] (Total) Time (Ttot): The total duration between the start of the inspiratory portion of one respiratory flow waveform and the start of the inspiratory portion of the subsequent respiratory flow waveform.

[0487] Typical Recent Ventilation: The ventilation value around which recent values ​​of ventilation Vent tend to cluster over some predetermined time scale, ie a measure of the central tendency of recent values ​​of ventilation.

[0488] Upper airway obstruction (UAO): includes partial and total upper airway obstruction. This may be associated with a state of flow limitation, where flow increases only slightly, or even decreases, as the pressure difference across the upper airway increases (Starling impedance behavior).

[0489] Ventilation (Vent): A measure of the rate of gas exchanged by a patient's respiratory system. Measurements of ventilation may include either or both of inspiratory and expiratory flow (per unit time). When expressed as volume per minute, this quantity is often referred to as "minute ventilation". Minute ventilation is sometimes given simply as volume, and is understood to be the volume per minute.

[0490] 4.9.3 Ventilation

[0491] Adaptive servo ventilator (ASV): A servo ventilator with a variable rather than fixed target ventilation. The variable target ventilation may be derived from some characteristic of the patient, such as the patient's breathing characteristics.

[0492] Backup Rate: A parameter of a ventilator that determines the minimum rate of breaths (usually measured in breaths per minute) that the ventilator will deliver to the patient if not triggered by a spontaneous respiratory effort.

[0493] Cyclic: The termination of the inspiratory phase of a ventilator. When a ventilator is delivering a breath to a spontaneously breathing patient, at the end of the inspiratory portion of the respiratory cycle, the ventilator is considered to cycle to stop delivering a breath.

[0494] Expiratory Positive Airway Pressure (EPAP): The base pressure to which intra-breath varying pressures are added to produce the desired interface pressure that the ventilator will attempt to achieve at a given time.

[0495] End-expiratory pressure (EEP): The desired interface pressure that the ventilator attempts to achieve at the end of the expiratory portion. If the pressure waveform template Π(Φ) is zero at the end of exhalation, that is, Π(Φ)=0, when Φ=1, then EEP is equal to EPAP.

[0496] Inspiratory Positive Airway Pressure (IPAP): The maximum desired interface pressure that the ventilator attempts to achieve during the inspiratory portion of a breath.

[0497] Pressure Support: A number that indicates the increase in pressure during ventilator inspiration over the pressure during ventilator expiration, and usually means the difference between the maximum and base pressure during inspiration (e.g., PS = IPAP - EPAP). In some cases, pressure support means the difference that the ventilator aims to achieve, rather than the difference that is actually achieved.

[0498] Servomotor: A ventilator that measures patient ventilation, has a target ventilation and adjusts the level of pressure support to bring the patient's ventilation to the target ventilation.

[0499] Spontaneous / Timed (S / T): A mode of a ventilator or other device that attempts to detect the onset of a breath in a spontaneously breathing patient. However, if the device cannot detect a breath within a predetermined period of time, the device will automatically initiate the delivery of a breath.

[0500] Swing: A term equivalent to pressure support.

[0501] Triggered: When the ventilator delivers breathed air to a spontaneously breathing patient, it is considered to be triggered at the beginning of the breath portion of the breathing cycle through the patient's effort.

[0502] 4.9.4 Anatomy

[0503] 4.9.4.1 Facial anatomy

[0504] Ala: The outer wall or "wing" of each nostril (plural: alar)

[0505] Alar tip: The outermost point on the wing of the nose.

[0506] Alar bend (or alar apex) point: The most posterior point in the base of the curvature of each ala, found in the crease formed by the union of the ala and cheek.

[0507] Auricle: The entire external visible part of the ear.

[0508] (Nose) Framework: The nasal framework includes the nasal bones, the frontal process of the maxilla, and the nasal part of the frontal bone.

[0509] Soft skeleton of the nose: The soft skeleton of the nose includes the septal, lateral, major and minor cartilages.

[0510] Columella: The strip of skin that separates the nostrils and extends from the nasal prominence to the upper lip.

[0511] Columellar angle: The angle between a line drawn through the midpoint of the nostril and a line drawn perpendicular to the Frankfort plane (where both lines intersect at the lower point of the nasal septum).

[0512] Frankfurt horizontal plane: A line extending from the lowest point of the orbital rim to the left cochlea. The cochlea is the deepest point in the notch above the tragus of the auricle.

[0513] Glabella: The most prominent point on the forehead in the midsagittal plane located on the soft tissue.

[0514] External nasal cartilage: A cartilaginous plate that is essentially triangular in shape. Its upper edge is connected to the nasal bone and the frontal process of the maxilla, and its lower edge is connected to the greater alar cartilage.

[0515] Lip, lower (midpoint of lower lip):

[0516] Lip, upper (midpoint of upper lip):

[0517] Greater alar cartilage: A cartilaginous plate located beneath the external nasal cartilage. It curves around the front of the nostril. Its rear end is connected to the frontal process of the maxilla by a tough fibrous membrane consisting of three or four small cartilages of the alar nasal cavity.

[0518] Nare: The roughly oval-shaped opening that forms the entrance to the nasal cavity. The singular form of nare is naris (nare). The nostrils are separated by the nasal septum.

[0519] Nasolabial Folds or Nasolabial Wrinkles: Folds or grooves of skin that extend from each side of the nose to the corners of the mouth, separating the cheeks from the upper lip.

[0520] Nasolabial angle: the angle between the columella and the upper lip (which intersect at the lower point of the nasal septum).

[0521] Auricular base: The lowest point where the auricle connects to the facial skin.

[0522] Auricular base: The highest point where the auricle connects to the facial skin.

[0523] Nasal prominence: The most prominent point or tip of the nose which can be identified in a side view of the rest of the head.

[0524] Philtrum: The midline groove that extends from the lower border of the nasal septum to the top of the lip in the upper lip area.

[0525] Mental point: The midpoint of the frontmost part of the chin located on the soft tissue.

[0526] Ridge (nose): The nasal ridge is the midline protrusion of the nose extending from the nasal bridge point to the nasal protuberance point.

[0527] Sagittal plane: A vertical plane that runs from anterior (front) to posterior (back). The midsagittal plane is the sagittal plane that divides the body into right and left halves.

[0528] Nasal point: The most concave point on the soft tissue covering the frontonasal suture area.

[0529] Septal Cartilage (Nose): The septal cartilage forms part of the septum and divides the front of the nasal chambers.

[0530] Posterior superior lateral flap: The point at the inferior edge of the alar base where the alar base joins the skin of the upper (superior) lip.

[0531] Subnasal point: The point on the soft tissue where the columella meets the upper lip in the midsagittal plane.

[0532] Mandibular alveolar seat point: the point of maximum concavity on the midline of the lower lip between the midpoint of the lower lip and the premental point of the soft tissue

[0533] 4.9.4.2 Anatomy of the skull

[0534] Frontal Bone: The frontal bone includes a large vertical portion (squama frontalis) which corresponds to the area called the forehead.

[0535] Mandible: The mandible forms the lower jaw. The mental protuberance is the bony protuberance of the lower jaw that forms the chin.

[0536] Maxilla: The maxilla forms the upper jaw and lies above the mandible and below the eye sockets. The frontal process of the maxilla projects upward from the sides of the nose and forms part of the lateral border.

[0537] Nasal Bones: The nasal bones are two small oval bones that vary in size and form among different individuals; they lie side by side in the middle and upper part of the face and form the "bridge" of the nose at their junction.

[0538] Nasal root: The intersection of the frontal bone and the two nasal bones, the concave area directly between the eyes and on the upper part of the bridge of the nose.

[0539] Occipital Bone: The occipital bone is located at the back and lower part of the skull. It contains the oval hole (foramen magnum) through which the cranial cavity communicates with the vertebral canal. The curved plate behind the foramen magnum is the squama occipitalis.

[0540] Orbit: The bony cavity in the skull that holds the eyeball.

[0541] Parietal bones: The parietal bones are the bones that when joined together form the roof and sides of the skull.

[0542] Temporal Bones: The temporal bones are located at the base and sides of the skull and support the part of the face called the temples.

[0543] Zygomatic bones: The face includes two zygomatic bones, which are located on the upper and side parts of the face and form the protuberances of the cheeks.

[0544] 4.9.4.3 Anatomy of the respiratory system

[0545] Diaphragm: A sheet of muscle that extends across the base of the rib cage. The diaphragm separates the thoracic cavity, which contains the heart, lungs, and ribs, from the abdominal cavity. As the diaphragm contracts, the volume of the thoracic cavity increases and air is drawn into the lungs.

[0546] Larynx: The larynx or voice box houses the vocal cords and connects the lower part of the pharynx (hypopharynx) to the trachea.

[0547] Lung: The respiratory organ of humans. The conducting zone of the lungs contains the trachea, bronchi, bronchioles, and terminal bronchioles. The respiratory zone contains the respiratory bronchioles, alveolar ducts, and alveoli.

[0548] Nasal Chamber: The nasal chamber (or nasal fossa) is the large air-filled space above and behind the nose in the middle of the face. The nasal chamber is divided into two parts by a vertical wing called the nasal septum. On the sides of the nasal chamber are three horizontal branches called the nasal conchae (singular "concha") or turbinates. The front of the nasal chamber is the nose, while the back joins into the nasopharynx via the internal nostrils.

[0549] Pharynx: The part of the throat located just below (under) the nasal cavity and above the esophagus and larynx. The pharynx is conventionally divided into three sections: the nasopharynx (epipharynx) (the nasal part of the pharynx), the oropharynx (mesopharynx) (the oral part of the pharynx), and the hypopharynx (hypopharynx).

[0550] 4.9.5 Patient Interface

[0551] Anti-Asphyxia Valve (AAV): reduces excessive CO in the patient by opening to atmosphere in a fail-safe manner 2 components or subcomponents of the mask system that present a risk of rebreathing.

[0552] Elbow: An elbow is an example of a structure that directs the axis of an air flow traveling therethrough to change direction through an angle. In one form, the angle may be approximately 90 degrees. In another form, the angle may be greater than or less than 90 degrees. The elbow may have a cross-section that is approximately circular. In another form, the elbow may have an elliptical or rectangular cross-section. In some forms, the elbow may be rotatable relative to a mating component, such as approximately 360 degrees. In some forms, the elbow may be removable from a mating component, such as via a snap-fit ​​connection. In some forms, the elbow may be assembled to a mating component via a one-time snap-fit ​​during manufacturing, but may not be removed by the patient.

[0553] Frame: A frame will be considered to mean the mask structure that carries the tensile load between two or more connection points to the headgear. A mask frame may be a non-airtight load-bearing structure in a mask. However, some forms of mask frames may also be airtight.

[0554] Headband: A headband will be considered to mean a form of positioning and stabilizing structure designed for use on the head. For example, a headband may include a collection of one or more support bars, straps, and reinforcements configured to position and maintain a patient interface in position on the patient's face for delivery of respiratory therapy. Some straps are formed of soft, flexible, resilient materials, such as a laminate composite of foam and fabric.

[0555] Film: A film shall be taken to mean a typically thin element which preferably has substantially no resistance to bending, but has resistance to stretching.

[0556] Plenum: A mask plenum will be taken to mean a portion of the patient interface having walls at least partially enclosing a volume of space which, in use, has air pressurized therein to above atmospheric pressure. The housing may form part of the wall of the mask plenum.

[0557] Seal: can be a noun form referring to a structure (seal) or a verb form referring to that effect (seal). Two elements can be constructed and / or arranged to 'seal' or achieve a 'seal' between them without the need for a separate 'seal' element itself.

[0558] Shell: Shell will be taken to mean a curved and relatively thin structure having bendable, stretchable and compressible stiffness. For example, a curved structural wall of a mask may be a shell. In some forms, the shell may be multi-faceted. In some forms, the shell may be airtight. In some forms, the shell may not be airtight.

[0559] Reinforcement: A reinforcement will be taken to mean a structural component designed to increase the bending resistance of another component in at least one direction.

[0560] Braces: Braces will be considered to be structural components designed to increase the compression resistance of another component in at least one direction.

[0561] Swivel (noun): A subassembly of a component configured to rotate about a common axis, preferably independently, preferably under low torque. In one form, the swivel may be configured to rotate through an angle of at least 360 degrees. In another form, the swivel may be configured to rotate through an angle of less than 360 degrees. When used in the context of an air delivery conduit, the subassembly of the component preferably comprises a pair of matching cylindrical conduits. There may be little or no air flow leakage from the swivel when in use.

[0562] Tie (noun): A structure used to resist tension.

[0563] Vent (noun): A structure that allows air flow from the interior of a mask or duct to ambient air, e.g., for effective flushing of exhaled gases. For example, clinically effective flushing may involve a flow rate of about 10 liters per minute to about 100 liters per minute, depending on the mask design and the therapy pressure.

[0564] 4.9.6 Shape of the structure

[0565] Products according to the present technology may include one or more three-dimensional mechanical structures, such as a mask cushion or a thruster. The three-dimensional structures may be combined by two-dimensional surfaces. These surfaces may be distinguished using markings to describe the relative surface orientation, position, function, or some other characteristics. For example, a structure may include one or more of a front surface, a rear surface, an inner surface, and an outer surface. In another example, a seal-forming structure may include a face-contacting (e.g., outer) surface and a separate non-face-contacting (e.g., underside or inner) surface. In another example, a structure may include a first surface and a second surface.

[0566] To help describe the shape of three-dimensional structures and surfaces, first consider a cross section through a point p on the surface of the structure, cf. FIG. 3B to FIG. 3F , which show a cross section at a point p on the surface and an example of the resulting plane curve. Figures 3B to 3F The outward normal vector at p is also shown. The outward normal vector at p points away from the surface. In some examples, the surface is described from the point of view of an imaginary person standing upright on the surface.

[0567] 4.9.6.1 One-dimensional curvature

[0568] The curvature of a plane curve at p can be described as having a sign (eg, positive, negative) and a magnitude (eg, the inverse of the radius of a circle that touches the curve only at p).

[0569] Positive curvature: If the curve at p turns toward the outward normal, then the curvature at that point will be positive (if the imaginary person leaves point p, they must be walking uphill). Figure 3B (and Figure 3C Compared to the relatively large positive curvature) and Figure 3C (and Figure 3B This type of curve is often called concave.

[0570] Zero curvature: If the curve at point p is a straight line, then the curvature will be zero (if the imaginary person leaves point p, they can walk horizontally without going up or down). Figure 3D .

[0571] Negative curvature: If the curve at p turns away from the outward normal, then the curvature in that direction at that point will be negative (if the imaginary person were to leave point p, they would have to go downhill). See Figure 3E (and Figure 3F Compared to the relatively small negative curvature) and Figure 3F (and Figure 3E This type of curve is often called convex.

[0572] 4.9.6.2 Curvature of two-dimensional surfaces

[0573] A description of a shape at a given point on a two-dimensional surface according to the present technology may include multiple normal cross sections. Multiple cross sections may cut the surface in a plane including an outward normal (a "normal plane"), and each cross section may be taken in a different direction. Each cross section produces a planar curve with a corresponding curvature. The different curvatures at the point may have the same sign or different signs. Each curvature at the point has a magnitude, such as a relatively small magnitude. Figures 3B to 3F A plane curve in can be an example of such multiple cross sections at specific points.

[0574] Principal curvatures and principal directions: The directions of the normal planes where the curvature of the curve takes its maximum and minimum values ​​are called principal directions. FIG. 3B to FIG. 3F In the example of Figure 3B The minimum curvature occurs in Figure 3F Therefore Figure 3B and Figure 3F is the cross section in the principal direction. The principal curvature at p is the curvature in the principal direction.

[0575] Region of a surface: A connected set of points on a surface. The set of points in a region can have similar characteristics, such as curvature or sign.

[0576] Saddle region: A region where at each point the principal curvatures have opposite signs, i.e. one sign is positive and the other is negative (depending on the direction the imagined individual is turning, they can be walking up or down).

[0577] Dome area: The area where at every point the principal curvatures have the same sign, e.g. two positive ("concave dome") or two negative ("convex dome").

[0578] Cylindrical region: A region where one of the principal curvatures is zero (or is zero within manufacturing tolerances, for example) and the other principal curvature is non-zero.

[0579] Planar Region: A surface region where both principal curvatures are zero (or are zero within manufacturing tolerances, for example).

[0580] Surface edge: The boundary or limit of a surface or area.

[0581] Path: In some forms of the present technology, 'path' will be taken to mean a path in the mathematical-topological sense, e.g. a continuous spatial curve from f(0) to f(1) on a surface. In some forms of the present technology, a 'path' may be described as a route or journey, comprising, e.g., a set of points on a surface. (A hypothetical person's path is where they walk on a surface, and is analogous to a garden path).

[0582] Path length: In some forms of the present technology, 'path length' will be considered to be the distance along the surface from f(0) to f(1), i.e. the distance along a path on the surface. There may be more than one path between two points on the surface, and such paths may have different path lengths. (The path length of an imaginary person would be the distance they would have to walk along a path on the surface.

[0583] Straight-line distance: Straight-line distance is the distance between two points on a surface, but regardless of the surface. On a planar area, there will be a path on the surface that has the same path length as the straight-line distance between two points on the surface. On a non-planar surface, there may not be a path that has the same path length as the straight-line distance between two points. (For the imaginary, straight-line distance would correspond to the distance "in a straight line")

[0584] 4.9.6.3 Space curve

[0585] Space curves: Unlike plane curves, space curves do not have to lie in any particular plane. Space curves can be closed, i.e., have no endpoints. Space curves can be thought of as one-dimensional segments of three-dimensional space. An imaginary person walking on one strand of a DNA helix walks along a space curve. A typical human left ear includes a helix that is a left-handed helix, see Figure 2i. A typical human right ear includes a helix that is a right-handed helix, see Figure 3R . Figure 3S A right-handed spiral is shown. The edge of a structure, such as the edge of a membrane or impeller, can follow a space curve. In general, a space curve can be described by the curvature and twist at each point on the space curve. Torque is a measure of how the curve turns out of the plane. Torque has a sign and a magnitude. The twist at a point on a space curve can be characterized with reference to the tangent vector, normal vector, and binormal vector at that point.

[0586] Tangent unit vector (or unit tangent vector): For each point on a curve, the vector at that point specifies the direction from said point as well as the magnitude. The tangent unit vector is a unit vector that points in the same direction as the curve at that point. If an imaginary person were flying along the curve and fell from her aircraft at a particular point, the direction of the tangent vector is the direction she would be traveling.

[0587] Unit Normal Vector: This tangent vector itself changes as the imaginary person moves along the curve. The unit vector pointing in the direction of the change in the tangent vector is called the unit principal normal vector. It is perpendicular to the tangent vector.

[0588] Binormal unit vector: The binormal unit vector is perpendicular to both the tangent vector and the principal normal vector. Its direction can be determined by the right-hand rule (see for example Figure 3P ) or optionally by the left-hand rule ( Fig.3O ) to determine.

[0589] Oscillating plane: The plane containing the unit tangent vector and the unit principal normal vector. Fig.3O and 3P .

[0590] Torsion of a space curve: The torsion of a space curve at a point is the magnitude of the rate of change of the binormal unit vector at the point. It measures how much the curve deviates from the osculating plane. A space curve that lies within the plane has zero torsion. A space curve that deviates from the osculating plane by a relatively small amount will have a relatively small amount of torsion (e.g., a gently inclined spiral path). A space curve that deviates from the osculating plane by a relatively large amount will have a relatively large amount of torsion (e.g., a sharply inclined spiral path). See Figure 3S Since T2>T1, the twist near the top coil of the spiral in Figure 3 is greater than Figure 3S The amount of twist in the bottom coil of the helix.

[0591] Reference Figure 3P According to the right-hand rule, a space curve with a right-hand binormal can be considered to have a right-hand positive twist (e.g., Figure 3S A space curve that turns away from the right-handed binormal direction can be considered to have right-handed negative twist (e.g., a left-handed helix).

[0592] Likewise, referring to the left-hand rule (see Fig.3O ), a space curve oriented in the direction of the left-handed binormal can be considered to have a left-handed positive twist (e.g., a left-handed helix). Thus left-handed positive is equivalent to right-handed negative. See Figure 3T .

[0593] 4.9.6.4 Holes

[0594] A surface can have one-dimensional pores, for example pores bounded by a plane curve or by a space curve. A thin structure (e.g., a membrane) with pores can be described as having one-dimensional pores. See, for example, Fig. 3I A one-dimensional hole in a surface bounded by a planar curve for the structure shown.

[0595] A structure can have a two-dimensional hole, such as a hole defined by a surface. For example, a pneumatic tire has a two-dimensional hole defined by the inner surface of the tire. In another example, a bladder having a cavity for air or gel can have a two-dimensional hole. For example, see Figure 3L The padding and the Figure 3M and Figure 3N An example cross section of a conduit is shown, which shows an inner surface defining a two-dimensional hole. In yet another example, a conduit can include a one-dimensional hole (e.g., at its inlet or at its outlet) and a two-dimensional hole defined by the inner surface of the conduit. See also Figure 3K A two-dimensional hole in the shown structure bounded by the shown surface.

[0596] 4.10 Other notes

[0597] A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent Office patent file or records, but otherwise reserves all copyright rights whatsoever.

[0598] Unless the context clearly indicates and provides a numerical range, it is understood that each intervening value between the upper and lower limits of the range, to one-tenth of the unit of the lower limit, and any other stated or intervening value in the stated range are broadly included in the present technology. The upper and lower limits of these intermediate ranges may be independently included in the intermediate ranges and are also included in the present technology, but are subject to any explicitly excluded limits in the stated ranges. In the case where a range includes one or both of the limits, the present technology also includes ranges excluding either or both of those included limits.

[0599] Furthermore, where a value or values ​​are described herein for implementation as part of the present technology, it should be understood that such values ​​may be approximate unless otherwise indicated and that such values ​​may be used to any appropriate number of significant digits as permitted or required by practical technical implementation.

[0600] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present technology, a limited number of exemplary methods and materials are described herein.

[0601] When a particular material is identified as being used to construct a component, obvious alternative materials having similar properties may be used as substitutes. In addition, unless otherwise specified, any and all components described herein are understood to be capable of being manufactured and thus may be manufactured together or separately.

[0602] It must be noted that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural equivalents unless the context clearly dictates otherwise.

[0603] All publications mentioned herein are incorporated herein in their entirety by reference, to disclose and describe methods and / or materials as the subject of those publications. The publications discussed herein are provided only for their disclosures before the filing date of the present application. This article should not be construed as admitting that the present technology is not entitled to be earlier than such disclosures due to prior inventions. In addition, the publication date provided may be different from the actual publication date, which may need to be confirmed separately.

[0604] The terms “comprises” and “comprising” should be understood to refer to elements, components or steps in a non-exclusive manner, indicating that the marked elements, components or steps may be present or utilized, or in combination with other elements, components or steps that are not marked.

[0605] The subject headings used in the detailed description are for the convenience of the reader and should not be used to limit the subject matter that can be found in the entire disclosure or claims. The subject headings should not be used to interpret the scope of the claims or claim limitations.

[0606] Although the present technology has been described herein with reference to specific embodiments, it should be understood that these embodiments only illustrate the principles and applications of the present technology. In some cases, terms and symbols may imply specific details that are not required for practical technology. For example, although the terms "first" and "second" may be used, unless otherwise specified, they are not intended to represent any order, but can be used to distinguish different elements. In addition, although the process steps in the method can be described or illustrated in sequence, such order is not required. Those skilled in the art will recognize that such order can be modified and / or aspects thereof can be performed simultaneously or even synchronously.

[0607] It is therefore to be understood that numerous modifications may be made to the example embodiments described and that other arrangements may be devised without departing from the spirit and scope of the present technology.

Claims

1. A patient interface, comprising: a frame formed of a flexible material and partially forming a plenum chamber pressurizable to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, the frame including a channel around a perimeter of the frame, the plenum chamber having at least one plenum chamber inlet port sized and configured to receive a flow of air at the therapeutic pressure for breathing by the patient; at least one pair of headband connectors connected to the frame; a seal-forming structure releasably connectable to the frame and partially forming the plenum chamber, the seal-forming structure being constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, the seal-forming structure having at least one aperture therein so that a flow of air at the therapy pressure is delivered to the patient's nares and to an entrance to the patient's mouth, the seal-forming structure being constructed and arranged, in use, to maintain the therapy pressure in the plenum chamber throughout the patient's breathing cycle, wherein the seal-forming structure comprises a foam under-cushion and a membrane portion, the membrane portion being connected to the foam under-cushion and configured to be inflated in use to form a seal against at least the nasal prominence area and the ala nasalis of the patient's nose, the seal-forming structure being further configured to form a seal around the patient's mouth; The foam under-cushion of the seal-forming structure includes a connecting portion on a non-patient-facing side of the foam under-cushion, the connecting portion being configured to be received in a channel of the frame to releasably connect the seal-forming structure to the frame.

2. A patient interface according to claim 1, wherein the frame is composed of an elastic material.

3. A patient interface according to claim 1 or 2, wherein the channel extends around the entire periphery of the frame.

4. A patient interface according to any one of claims 1-3, wherein the channel and the foam underpad are engaged to form a seal.

5. A patient interface according to any one of claims 1-4, wherein the channel has a generally C-shaped cross-section.

6. A patient interface according to any one of claims 1-5, wherein the channel opens outwardly relative to the frame, and the connecting portion of the foam lower pad includes an opening having a periphery facing inwardly relative to the opening, the periphery of the opening being configured to fit within the channel.

7. A patient interface according to any one of claims 1-6, wherein the connecting portion is configured to be press-fit into the channel.

8. A patient interface according to any one of claims 1-7, wherein the foam cushion is configured to hold the membrane portion substantially taut when the patient interface is not in use.

9. A patient interface according to any one of claims 1-8, wherein the membrane portion is connected to the foam undercushion around the periphery of the membrane portion.

10. A patient interface according to any one of claims 1-9, wherein the membrane portion is bonded to the foam undercushion.

11. A patient interface according to any one of claims 1-10, wherein the membrane portion includes a first hole through which air can flow to both nostrils of the patient in use.

12. A patient interface according to claim 11, wherein the membrane portion is configured to be stretched by the patient's nose adjacent the first aperture in use.

13. A patient interface according to claim 11 or 12, wherein the membrane portion includes a second aperture through which air can flow to the patient's mouth in use.

14. A patient interface according to any one of claims 1-13, wherein the membrane portion is at least partially formed from a textile material.

15. A patient interface according to claim 14, wherein the fabric material forms a patient-facing side of the membrane portion, and the membrane portion further comprises an air-impermeable coating on a non-patient-facing side thereof.

16. A patient interface according to any one of claims 1-15, wherein the foam under-cushion includes a nasal portion, the nasal portion is configured to be positioned near a lower periphery of the patient's nose during use, the foam under-cushion includes a nasal recess located in the nasal portion, the nasal recess is configured to prevent the sealing forming structure from obstructing the patient's nose.

17. A patient interface according to claim 16, wherein the nasal recess comprises a shape corresponding to a lower periphery of the patient's nose.

18. A patient interface according to claim 16 or 17, wherein the membrane portion is connected to the foam undercushion around the periphery of the nasal recess.

19. A patient interface according to any one of claims 1-18, wherein the frame has a non-zero negative first principal curvature and a second principal curvature that is less than the first principal curvature.

20. A patient interface according to claim 19, wherein the second principal curvature is substantially zero and is substantially parallel to the sagittal plane of the patient in use.

21. A patient interface according to claim 19 or 20, wherein the frame is curved such that when worn by a patient with a narrow face, the first principal curvature has a greater magnitude than when worn by a patient with a relatively wider face.

22. A patient interface according to any one of claims 1-21, wherein the at least one pair of headband connector portions comprises a pair of upper headband connector portions connected to the frame and a pair of lower headband connector portions connected to the frame.

23. A patient interface according to claim 22, wherein each of the upper headband connector portions includes a curved arm.

24. A patient interface according to claim 22 or 23, wherein the lower headband connector portion comprises a magnetic connector.

25. A patient interface comprising: a frame that partially forms a plenum chamber that is pressurizable to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, the plenum chamber having at least one plenum chamber inlet port sized and configured to receive a flow of air at the therapeutic pressure for breathing by the patient, at least one pair of headband connectors connected to the frame; a seal-forming structure connected to the frame and partially forming the plenum chamber, the seal-forming structure being constructed and arranged to form a seal with an area of ​​the patient's face surrounding an entrance to the patient's airway, the seal-forming structure having at least one aperture therein so that a flow of air at the therapeutic pressure is delivered to the patient's nares and to an entrance to the patient's mouth, the seal-forming structure being constructed and arranged, in use, to maintain the therapeutic pressure in the plenum chamber throughout the patient's breathing cycle, wherein the seal-forming structure comprises a lower cushion and a membrane portion, the membrane portion being connected to the lower cushion and configured to be inflated in use to form a seal against at least the nasal prominence area and the nasal wings of the patient's nose, the seal-forming structure being further configured to form a seal around the patient's mouth; The lower cushion includes a nasal portion, which is configured to be positioned adjacent to a lower periphery of the patient's nose during use, the lower cushion includes a nasal recess in the nasal portion, the nasal recess includes an inwardly facing wall, the inwardly facing wall is configured to face and at least partially surround the lower periphery of the patient's nose during use, and the membrane portion is supported by the lower cushion at the periphery of the nasal recess.

26. A patient interface according to claim 25, wherein the nasal recess is configured to avoid engaging both lateral sides of the patient's nose simultaneously.

27. A patient interface according to claim 25 or 26, wherein the nasal recess is constructed to provide substantially no medially directed force on the nasal ala of the patient in use.

28. A patient interface according to any one of claims 25-27, wherein the nasal recess is constructed and arranged such that in use the lower cushion exerts substantially no force on the patient's nose.

29. A patient interface according to any one of claims 25-28, wherein the nasal recess is configured to prevent the seal-forming structure from obstructing the patient's nose during use.

30. A patient interface according to any one of claims 25-29, wherein the nasal recess comprises a shape corresponding to a lower periphery of the patient's nose.

31. A patient interface according to any one of claims 25-30, wherein in use, the nasal recess surrounds substantially all of the lateral and forward facing portions of the lower periphery of the patient's nose.

32. A patient interface according to any one of claims 25-31, wherein the inwardly facing wall extends from around the patient's nose at or near one cheek of the patient to at or near the other cheek of the patient.

33. A patient interface according to any one of claims 25-32, wherein the membrane portion is connected to the lower cushion around the periphery of the nasal recess.

34. A patient interface according to claim 33, wherein the lower cushion includes an upward facing surface, the upward facing surface being disposed adjacent to and around a periphery of the nasal recess, the membrane portion being connected to the upward facing surface of the lower cushion.

35. A patient interface according to any one of claims 25-34, wherein: The inwardly facing wall has a concave cross-section in a horizontal plane parallel to the Frankfurt horizontal plane of the patient's head.

36. A patient interface according to any one of claims 25-35, wherein the inwardly facing wall has a concave cross-section in the sagittal plane and / or in a vertical plane parallel to the coronal plane.

37. A patient interface according to any one of claims 25-36, wherein the lower cushion includes a pair of rear support portions, each rear support portion is positioned on a corresponding lateral side of the nasal recess and is configured to engage the patient's face in the middle and near the nasolabial groove of the patient's face.

38. A patient interface according to claim 37, wherein the rear support portion engages the patient's face at a position below the nose ala on either side above the patient's lips and / or at a position vertically aligned with the patient's nose ala between the nose ala and the nasolabial groove.

39. A patient interface according to claim 37 or claim 38, wherein the rear support portion is formed to project at least partially centrally into a recess formed on the patient's face on either lateral side of the patient's nasal wing.

40. A patient interface according to any one of claims 37-39, wherein the inwardly facing wall extends from a first one of the rear support portions surrounding the patient's nose to another one of the rear support portions.

41. A patient interface according to any one of claims 25-40, wherein the seal-forming structure is releasably connected to the frame.

42. A patient interface according to claim 41, wherein the frame includes a channel around the periphery of the frame, and the lower pad of the seal-forming structure includes a connecting portion on a side of the lower pad that does not face the patient, the connecting portion being configured to be received in the channel of the frame to releasably connect the seal-forming structure to the frame.

43. A patient interface according to any one of claims 25-42, wherein said lower cushion is configured to hold said membrane portion substantially taut when said patient interface is not in use.

44. A patient interface according to any one of claims 25-43, wherein the membrane portion is connected to the lower cushion around an outer periphery of the membrane portion.

45. A patient interface according to any one of claims 25-44, wherein the membrane portion includes a first aperture through which air can flow to both nostrils of the patient, in use.

46. ​​A patient interface according to claim 45, wherein the membrane portion is configured to be stretched by the patient's nose adjacent the first aperture in use.

47. A patient interface according to claim 45 or 46, wherein the membrane portion includes a second aperture through which air can flow to the patient's mouth, in use.

48. A patient interface according to any one of claims 25-47, wherein the membrane portion is at least partially formed from a fabric material.

49. A patient interface according to claim 48, wherein the fabric material forms a patient-facing side of the membrane portion, and the membrane portion further comprises an air-impermeable coating on a non-patient-facing side thereof.

50. A patient interface according to any one of claims 25-49 wherein the lower cushion is formed from foam.

51. A patient interface according to any one of claims 25-50, wherein the frame is formed from a flexible material.

52. A patient interface according to any one of claims 25-51, wherein the frame has a non-zero negative first principal curvature and a second principal curvature that is less than the first principal curvature.

53. A patient interface according to claim 52, wherein the second principal curvature is substantially zero and is substantially parallel to the sagittal plane of the patient in use.

54. A patient interface according to claim 52 or 53, wherein the frame is curved such that when worn by a patient with a narrow face, the first principal curvature has a greater magnitude than when worn by a patient with a relatively wider face.